Acute Otitis Media, Mastoiditis
Conditions
Keywords
Acute otitis media, Prevnar 13, Streptococcus pneumoniae
Brief summary
Prevnar (7 valent pneumococcal conjugate vaccine \[7vPnC\]) has been shown to be effective against ear infections in children. Prevnar 13 is a new vaccine that is similar to Prevnar. It is expected that the effectiveness of Prevnar 13 against ear infections in children will be similar to that observed following Prevnar. Pfizer has committed to conduct a postmarketing study of the impact of Prevnar 13 in reducing ear infections among children.
Interventions
OTHERNo intervention
Non interventional
Sponsors
Pfizer
Study design
Observational model
CASE_ONLY
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
0 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Case eligibility should be based on microbiologic data and should be reviewed and documented by an appropriately qualified member of the investigator's study team before cases are included in the study database. * S pneumoniae identified from middle ear fluid or mastoiditis sample. * Specimen obtained from children aged up to 18 years.
Exclusion criteria
* As this is an observational, laboratory based database study, there are no
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 1 | Surveillance Year 1 | The distribution of S pneumoniae serotypes isolated from MEF samples from children in the target population for vaccination over the surveillance year 1 were presented. The percentage of isolates of S pneumoniae serotypes included in Prevnar 13 (3, 7F, 19A, 19F) and not included in Prevnar 13 (6C, 7C, 9N, 10, 11, 12, 12F, 13, 15A, 15B, 15C, 15F, 16, 17, 20, 21, 22F, 23A, 23B, 31, 33A, 33F, 34, 35B, 35F, 38) along with total (both included and not included), clumps and missing or non-viable were computed along with exact 2-sided 95 percent (%) confidence interval (CI) based on the observed proportion of isolates. Missing or non-viable included isolates that were either not sent from an external laboratory, were non-viable or lost on culture prior to sending, or were non-viable on receipt in the central laboratory.'Number of isolates analyzed' signifies total number of isolates that were evaluable for this outcome measure (OM). |
| Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 2 | Surveillance Year 2 | The distribution of S pneumoniae serotypes isolated from MEF samples from children in the target population for vaccination over the surveillance year 2 were presented. The percentage of isolates of S pneumoniae serotypes included in Prevnar 13 (3, 7F, 19A, 19F) and not included in Prevnar 13 (6C, 7C, 9N, 10, 11, 12, 12F, 13, 15A, 15B, 15C, 15F, 16, 17, 20, 21, 22F, 23A, 23B, 31, 33A, 33F, 34, 35B, 35F, 38) along with total (both included and not included), clumps and missing or non-viable were computed along with exact 2-sided 95% CI based on the observed proportion of isolates. Missing or non-viable included isolates that were either not sent from an external laboratory, were non-viable or lost on culture prior to sending, or were non-viable on receipt in the central laboratory.'Number of isolates analyzed' signifies total number of isolates that were evaluable for this OM. |
| Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 3 | Surveillance Year 3 | The distribution of S pneumoniae serotypes isolated from MEF samples from children in the target population for vaccination over the surveillance year 3 were presented. The percentage of isolates of S pneumoniae serotypes included in Prevnar 13 (3, 7F, 19A, 19F) and not included in Prevnar 13 (6C, 7C, 9N, 10, 11, 12, 12F, 13, 15A, 15B, 15C, 15F, 16, 17, 20, 21, 22F, 23A, 23B, 31, 33A, 33F, 34, 35B, 35F, 38) along with total (both included and not included), clumps and missing or non-viable were computed along with exact 2-sided 95% CI based on the observed proportion of isolates. Missing or non-viable included isolates that were either not sent from an external laboratory, were non-viable or lost on culture prior to sending, or were non-viable on receipt in the central laboratory.'Number of isolates analyzed' signifies total number of isolates that were evaluable for this OM. |
| Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 1 | Surveillance Year 1 | The distribution of S pneumoniae serotypes isolated from mastoiditis samples from children in the target population for vaccination over the surveillance year 1 were presented. The percentage of isolates of S pneumoniae serotypes included in Prevnar 13 (1, 3, 7F, 14, 19A, 19F) and not included in Prevnar 13 (6C, 12, 15A, 15B, 15F, 21, 22F, 23A, 33F, 35B, 38) along with total (both included and not included in Prevnar 13 ), clumps and missing or non-viable were computed along with exact 2-sided 95% CI based on the observed proportion of isolates. Missing or non-viable included isolates that were either not sent from an external laboratory, were non-viable or lost on culture prior to sending, or were non-viable on receipt in the central laboratory.'Number of isolates analyzed' signifies total number of isolates that were evaluable for this OM. |
| Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 2 | Surveillance Year 2 | The distribution of S pneumoniae serotypes isolated from mastoiditis samples from children in the target population for vaccination over the surveillance year 2 were presented. The percentage of isolates of S pneumoniae serotypes included in Prevnar 13 (1, 3, 7F, 14, 19A, 19F) and not included in Prevnar 13 (6C, 12, 15A, 15B, 15F, 21, 22F, 23A, 33F, 35B, 38) along with total (both included and not included in Prevnar 13 ), clumps and missing or non-viable were computed along with exact 2-sided 95% CI based on the observed proportion of isolates. Missing or non-viable included isolates that were either not sent from an external laboratory, were non-viable or lost on culture prior to sending, or were non-viable on receipt in the central laboratory.'Number of isolates analyzed' signifies total number of isolates that were evaluable for this OM. |
| Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 3 | Surveillance Year 3 | The distribution of S pneumoniae serotypes isolated from mastoiditis samples from children in the target population for vaccination over the surveillance year 3 were presented. The percentage of isolates of S pneumoniae serotypes included in Prevnar 13 (1, 3, 7F, 14, 19A, 19F) and not included in Prevnar 13 (6C, 12, 15A, 15B, 15F, 21, 22F, 23A, 33F, 35B, 38) along with total (both included and not included in Prevnar 13 ), clumps and missing or non-viable were computed along with exact 2-sided 95% CI based on the observed proportion of isolates. Missing or non-viable included isolates that were either not sent from an external laboratory, were non-viable or lost on culture prior to sending, or were non-viable on receipt in the central laboratory.'Number of isolates analyzed' signifies total number of isolates that were evaluable for this OM. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Surveillance Year 1, 2, 3 | Antimicrobial susceptibility of S pneumoniae isolates for TMP/S from MEF samples was categorized as resistant, susceptible or intermediate based on MIC for each serotype at each year of the whole surveillance period. The percentage of S pneumoniae serotypes included 3, 6C, 7C, 9N, 10, 11, 12, 12F, 13, 15A, 15B, 15C, 15F, 16, 17, 19A, 19F, 20, 21, 22F, 23A, 23B, 31, 33A, 33F, 34, 35B, 35F, 38, clumps and missing or non-viable, which were to be computed along with exact 2-sided 95% CI based on the observed proportion of isolates. Missing or non-viable included isolates that were either not sent from an external laboratory, were non-viable or lost on culture prior to sending, or were non-viable on receipt in the central laboratory.'Number of isolates analyzed' signifies total number of isolates that were evaluable for this OM. |
| Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population | Surveillance Year 1, 2, 3 | Antimicrobial susceptibility of S pneumoniae isolates for ceftriaxone from mastoid samples was categorized as resistant, susceptible or intermediate based on MIC for each serotype at each year of the whole surveillance period. The percentage of S pneumoniae serotypes included 3, 12, 15A, 15B, 15F, 19A, 19F, 21, 22F, 23A, 38, which were to be computed along with exact 2-sided 95% CI based on the observed proportion of isolates. 'Number of isolates analyzed' signifies total number of isolates that were evaluable for this OM. |
| Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population | Surveillance Year 1, 2, 3 | Antimicrobial susceptibility of S pneumoniae isolates for clindamycin from mastoid samples was categorized as resistant, susceptible or intermediate based on MIC for each serotype at each year of the whole surveillance period. The percentage of S pneumoniae serotypes included 3, 12, 15A, 15B, 15F, 19A, 19F, 21, 22F, 23A, 38, which were to be computed along with exact 2-sided 95% CI based on the observed proportion of isolates. 'Number of isolates analyzed' signifies total number of isolates that were evaluable for this OM. |
| Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population | Surveillance Year 1, 2, 3 | Antimicrobial susceptibility of S pneumoniae isolates for erythromycin from mastoid samples was categorized as resistant, susceptible or intermediate based on MIC for each serotype at each year of the whole surveillance period. The percentage of S pneumoniae serotypes included 3, 12, 15A, 15B, 15F, 19A, 19F, 21, 22F, 23A, 38, which were to be computed along with exact 2-sided 95% CI based on the observed proportion of isolates. 'Number of isolates analyzed' signifies total number of isolates that were evaluable for this OM. |
| Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Surveillance Year 1, 2, 3 | Antimicrobial susceptibility of S pneumoniae isolates for amoxicillin from MEF samples was categorized as resistant, susceptible or intermediate based on minimum inhibitory concentration (MIC) for each serotype at each year of the whole surveillance period. The percentage of S pneumoniae serotypes included 3, 6C, 7C, 9N, 10, 11, 12, 12F, 13, 15A, 15B, 15C, 15F, 16, 17, 19 A, 19 F, 20, 21, 22F, 23A, 23B, 31, 33A, 33F, 34, 35B, 35F, 38, clumps and missing or non-viable, which were to be computed along with exact 2-sided 95% CI based on the observed proportion of isolates. Missing or non-viable included isolates that were either not sent from an external laboratory, were non-viable or lost on culture prior to sending, or were non-viable on receipt in the central laboratory.'Number of isolates analyzed' signifies total number of isolates that were evaluable for this OM. |
| Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population | Surveillance Year 1, 2, 3 | Antimicrobial susceptibility of S pneumoniae isolates for TMP/S from mastoid samples was categorized as resistant, susceptible or intermediate based on MIC for each serotype at each year of the whole surveillance period. The percentage of S pneumoniae serotypes included 3, 12, 15A, 15B, 15F, 19A, 19F, 21, 22F, 23A, 38, which were to be computed along with exact 2-sided 95% CI based on the observed proportion of isolates. 'Number of isolates analyzed' signifies total number of isolates that were evaluable for this OM. |
| Percentage of Participants With Primary Clinical Diagnosis of Otitis Media | Baseline Year 1, 2, 3; Surveillance Year 1, 2, 3 | Percentage of participants with primary diagnosis of otitis media was computed along with exact 2-sided 95% CI based on the observed proportion of participants for each of the 3 surveillance year. Results for baseline period were analyzed for participants who received routinely recommended vaccination of 13vPnC. The cases of otitis media reported during the baseline period were captured by the Texas Children's Hospital, which was the only site that collected this information during the baseline period. Percentage of participants was calculated by dividing number of participants with at least 1 MEF sample for the specified year by total number of participants with at least 1 MEF sample for the 3 year surveillance period. |
| Percentage of Participants With Primary Clinical Diagnosis of Mastoiditis | Surveillance Year 1, 2, 3 | Percentage of participants with primary diagnosis of mastoiditis was computed along with exact 2-sided 95% CI based on the observed proportion of participants for each of the 3 surveillance year. Percentage of participants was calculated by dividing number of participants with at least 1 mastoid sample for the specified year by total number of participants with at least 1 mastoid sample for the 3 year surveillance period. |
| Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population | Surveillance Year 1, 2, 3 | Antimicrobial susceptibility of S pneumoniae isolates for penicillin from mastoid samples was categorized as resistant, susceptible or intermediate based on MIC for each serotype at each year of the whole surveillance period. The percentage of S pneumoniae serotypes included 3, 12, 15A, 15B, 15F, 19A, 19F, 21, 22F, 23A, 38, which were to be computed along with exact 2-sided 95% CI based on the observed proportion of isolates. 'Number of isolates analyzed' signifies total number of isolates that were evaluable for this OM. |
| Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Surveillance Year 1, 2, 3 | Antimicrobial susceptibility of S pneumoniae isolates for cefotaxime from MEF samples was categorized as resistant, susceptible or intermediate based on MIC for each serotype at each year of the whole surveillance period. The percentage of S pneumoniae serotypes included 3, 6C, 7C, 9N, 10, 11, 12, 12F, 13, 15A, 15B, 15C, 15F, 16, 17, 19 A, 19 F, 20, 21, 22F, 23A, 23B, 31, 33A, 33F, 34, 35B, 35F, 38, clumps and missing or non-viable, which were to be computed along with exact 2-sided 95% CI based on the observed proportion of isolates. Missing or non-viable included isolates that were either not sent from an external laboratory, were non-viable or lost on culture prior to sending, or were non-viable on receipt in the central laboratory.'Number of isolates analyzed' signifies total number of isolates that were evaluable for this OM. |
| Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Surveillance Year 1, 2, 3 | Antimicrobial susceptibility of S pneumoniae isolates for ceftriaxone from MEF samples was categorized as resistant, susceptible or intermediate based on MIC for each serotype at each year of the whole surveillance period. The percentage of S pneumoniae serotypes included 3, 6C, 7C, 9N, 10, 11, 12, 12F, 13, 15A, 15B, 15C, 15F, 16, 17, 19 A, 19 F, 20, 21, 22F, 23A, 23B, 31, 33A, 33F, 34, 35B, 35F, 38, clumps and missing or non-viable, which were to be computed along with exact 2-sided 95% CI based on the observed proportion of isolates. Missing or non-viable included isolates that were either not sent from an external laboratory, were non-viable or lost on culture prior to sending, or were non-viable on receipt in the central laboratory.'Number of isolates analyzed' signifies total number of isolates that were evaluable for this OM. |
| Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Surveillance Year 1, 2, 3 | Antimicrobial susceptibility of S pneumoniae isolates for clindamycin from MEF samples was categorized as resistant, susceptible or intermediate based on MIC for each serotype at each year of the whole surveillance period. The percentage of S pneumoniae serotypes included 3, 6C, 7C, 9N, 10, 11, 12, 12F, 13, 15A, 15B, 15C, 15F, 16, 17, 19 A, 19 F, 20, 21, 22F, 23A, 23B, 31, 33A, 33F, 34, 35B, 35F, 38, clumps and missing or non-viable, which were to be computed along with exact 2-sided 95% CI based on the observed proportion of isolates. Missing or non-viable included isolates that were either not sent from an external laboratory, were non-viable or lost on culture prior to sending, or were non-viable on receipt in the central laboratory.'Number of isolates analyzed' signifies total number of isolates that were evaluable for this OM. |
| Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Surveillance Year 1, 2, 3 | Antimicrobial susceptibility of S pneumoniae isolates for erythromycin from MEF samples was categorized as resistant, susceptible or intermediate based on MIC for each serotype at each year of the whole surveillance period. The percentage of S pneumoniae serotypes included 3, 6C, 7C, 9N, 10, 11, 12, 12F, 13, 15A, 15B, 15C, 15F, 16, 17, 19A, 19F, 20, 21, 22F, 23A, 23B, 31, 33A, 33F, 34, 35B, 35F, 38, clumps and missing or non-viable, which were to be computed along with exact 2-sided 95% CI based on the observed proportion of isolates. Missing or non-viable included isolates that were either not sent from an external laboratory, were non-viable or lost on culture prior to sending, or were non-viable on receipt in the central laboratory.'Number of isolates analyzed' signifies total number of isolates that were evaluable for this OM. |
| Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Surveillance Year 1, 2, 3 | Antimicrobial susceptibility of S pneumoniae isolates for penicillin from MEF samples were summarized by providing the range of MICs for penicillin tested and the percentage of the susceptibility interpretation was categorized as resistant, susceptible or intermediate for each serotype, and for each year of the whole surveillance period. The percentage of S pneumoniae serotypes included 3, 6C, 7C, 9N, 10, 11, 12, 12F, 13, 15A, 15B, 15C, 15F, 16, 17, 19 A, 19 F, 20, 21, 22F, 23A, 23B, 31, 33A, 33F, 34, 35B, 35F, 38, clumps and missing or non-viable, which were to be computed along with exact 2-sided 95 % CI based on the observed proportion of isolates. Missing or non-viable included isolates that were either not sent from an external laboratory, were non-viable or lost on culture prior to sending, or were non-viable on receipt in the central laboratory.'Number of isolates analyzed' signifies total number of isolates that were evaluable for this OM. |
Countries
United States
Participant flow
Pre-assignment details
This study is a 3-year prospective laboratory-based surveillance study wherein the results of the samples obtained were summarized separately for each year. In this study, no more than 1 sample was obtained from a participant and no more than 1 serotype was isolated from any sample.
Participants by arm
| Arm | Count |
|---|---|
| MEF Population Participants with Streptococcus pneumoniae (S pneumoniae) isolates from middle ear fluid (MEF) sample without regard to whether or not they received routinely recommended vaccination of 13-valent pneumococcal conjugate vaccine (13vPnC, Prevnar 13) according to the Advisory Committee on Immunization Practices (ACIP)-recommended schedule during a surveillance period starting from December 20, 2010 through December 31, 2013. | 357 |
| Mastoid Population Participants with S pneumoniae isolates from mastoid sample without regard to whether or not they received routinely recommended vaccination of 13-valent pneumococcal conjugate vaccine (13vPnC, Prevnar 13) according to the Advisory Committee on Immunization Practices (ACIP)-recommended schedule during a surveillance period starting from December 20, 2010 through December 31, 2013. | 34 |
| Total | 391 |
Baseline characteristics
| Characteristic | MEF Population | Mastoid Population | Total |
|---|---|---|---|
| Age, Continuous | 28.7 months STANDARD_DEVIATION 26 | 35.5 months STANDARD_DEVIATION 47.2 | 29.3 months STANDARD_DEVIATION 28.5 |
| Sex/Gender, Customized Female | 144 Participants | 18 Participants | 162 Participants |
| Sex/Gender, Customized Male | 209 Participants | 16 Participants | 225 Participants |
| Sex/Gender, Customized Not collected | 4 Participants | 0 Participants | 4 Participants |
Adverse events
| Event type | EG000 affected / at risk | EG001 affected / at risk |
|---|---|---|
| deaths Total, all-cause mortality | — / — | — / — |
| other Total, other adverse events | 0 / 0 | 0 / 0 |
| serious Total, serious adverse events | 0 / 0 | 0 / 0 |
Outcome results
Primary
Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 1
The distribution of S pneumoniae serotypes isolated from mastoiditis samples from children in the target population for vaccination over the surveillance year 1 were presented. The percentage of isolates of S pneumoniae serotypes included in Prevnar 13 (1, 3, 7F, 14, 19A, 19F) and not included in Prevnar 13 (6C, 12, 15A, 15B, 15F, 21, 22F, 23A, 33F, 35B, 38) along with total (both included and not included in Prevnar 13 ), clumps and missing or non-viable were computed along with exact 2-sided 95% CI based on the observed proportion of isolates. Missing or non-viable included isolates that were either not sent from an external laboratory, were non-viable or lost on culture prior to sending, or were non-viable on receipt in the central laboratory.'Number of isolates analyzed' signifies total number of isolates that were evaluable for this OM.
Time frame: Surveillance Year 1
Population: Mastoid population included all participants who have at least 1 S pneumoniae isolate from mastoid samples. N (number of participants analyzed) includes total number of participants in mastoid population, however actual 'N' for this OM is unknown as this data were not calculated as per planned analysis.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 1 | Serotype included in Prevnar 13:1 | 0.0 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 1 | Serotype included in Prevnar 13:3 | 0.0 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 1 | Serotype included in Prevnar 13:7F | 0.0 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 1 | Serotype included in Prevnar 13:14 | 0.0 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 1 | Serotype included in Prevnar 13:19A | 38.9 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 1 | Serotype included in Prevnar 13:19F | 11.1 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 1 | Total Serotype included in Prevnar 13 | 50.0 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 1 | Serotype not included in Prevnar 13:6C | 5.6 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 1 | Serotype not included in Prevnar 13:12 | 5.6 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 1 | Serotype not included in Prevnar 13:15A | 5.6 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 1 | Serotype not included in Prevnar 13:15B | 5.6 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 1 | Serotype not included in Prevnar 13:15F | 0.0 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 1 | Serotype not included in Prevnar 13:21 | 0.0 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 1 | Serotype not included in Prevnar 13:22F | 11.1 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 1 | Serotype not included in Prevnar 13:23A | 5.6 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 1 | Serotype not included in Prevnar 13:33F | 0.0 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 1 | Serotype not included in Prevnar 13:35B | 5.6 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 1 | Serotype not included in Prevnar 13:38 | 5.6 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 1 | Total Serotype not included in Prevnar 13 | 50.0 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 1 | Serotype missing/non-viable | 0.0 percentage of isolates |
Primary
Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 2
The distribution of S pneumoniae serotypes isolated from mastoiditis samples from children in the target population for vaccination over the surveillance year 2 were presented. The percentage of isolates of S pneumoniae serotypes included in Prevnar 13 (1, 3, 7F, 14, 19A, 19F) and not included in Prevnar 13 (6C, 12, 15A, 15B, 15F, 21, 22F, 23A, 33F, 35B, 38) along with total (both included and not included in Prevnar 13 ), clumps and missing or non-viable were computed along with exact 2-sided 95% CI based on the observed proportion of isolates. Missing or non-viable included isolates that were either not sent from an external laboratory, were non-viable or lost on culture prior to sending, or were non-viable on receipt in the central laboratory.'Number of isolates analyzed' signifies total number of isolates that were evaluable for this OM.
Time frame: Surveillance Year 2
Population: Mastoid population included all participants who have at least 1 S pneumoniae isolate from mastoid samples. N (number of participants analyzed) includes total number of participants in mastoid population, however actual 'N' for this OM is unknown as this data were not calculated as per planned analysis.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 2 | Serotype included in Prevnar 13:1 | 0.0 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 2 | Serotype included in Prevnar 13:3 | 28.6 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 2 | Serotype included in Prevnar 13:7F | 0.0 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 2 | Serotype included in Prevnar 13:14 | 0.0 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 2 | Serotype included in Prevnar 13:19A | 71.4 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 2 | Serotype included in Prevnar 13:19F | 0.0 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 2 | Total Serotype included in Prevnar 13 | 100.0 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 2 | Serotype not included in Prevnar 13:6C | 0.0 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 2 | Serotype not included in Prevnar 13:12 | 0.0 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 2 | Serotype not included in Prevnar 13:15A | 0.0 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 2 | Serotype not included in Prevnar 13:15B | 0.0 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 2 | Serotype not included in Prevnar 13:15F | 0.0 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 2 | Serotype not included in Prevnar 13:21 | 0.0 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 2 | Serotype not included in Prevnar 13:22F | 0.0 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 2 | Serotype not included in Prevnar 13:23A | 0.0 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 2 | Serotype not included in Prevnar 13:33F | 0.0 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 2 | Serotype not included in Prevnar 13:35B | 0.0 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 2 | Serotype not included in Prevnar 13:38 | 0.0 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 2 | Total Serotype not included in Prevnar 13 | 0.0 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 2 | Serotype missing/non-viable | 0.0 percentage of isolates |
Primary
Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 3
The distribution of S pneumoniae serotypes isolated from mastoiditis samples from children in the target population for vaccination over the surveillance year 3 were presented. The percentage of isolates of S pneumoniae serotypes included in Prevnar 13 (1, 3, 7F, 14, 19A, 19F) and not included in Prevnar 13 (6C, 12, 15A, 15B, 15F, 21, 22F, 23A, 33F, 35B, 38) along with total (both included and not included in Prevnar 13 ), clumps and missing or non-viable were computed along with exact 2-sided 95% CI based on the observed proportion of isolates. Missing or non-viable included isolates that were either not sent from an external laboratory, were non-viable or lost on culture prior to sending, or were non-viable on receipt in the central laboratory.'Number of isolates analyzed' signifies total number of isolates that were evaluable for this OM.
Time frame: Surveillance Year 3
Population: Mastoid population included all participants who have at least 1 S pneumoniae isolate from mastoid samples. N (number of participants analyzed) includes total number of participants in mastoid population, however actual 'N' for this OM is unknown as this data were not calculated as per planned analysis.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 3 | Serotype not included in Prevnar 13:23A | 0.0 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 3 | Serotype not included in Prevnar 13:33F | 22.2 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 3 | Serotype not included in Prevnar 13:35B | 0.0 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 3 | Serotype not included in Prevnar 13:38 | 0.0 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 3 | Total Serotype not included in Prevnar 13 | 33.3 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 3 | Serotype missing/non-viable | 0.0 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 3 | Serotype included in Prevnar 13:1 | 0.0 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 3 | Serotype included in Prevnar 13:3 | 44.4 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 3 | Serotype included in Prevnar 13:7F | 0.0 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 3 | Serotype included in Prevnar 13:14 | 0.0 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 3 | Serotype included in Prevnar 13:19A | 11.1 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 3 | Serotype included in Prevnar 13:19F | 11.1 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 3 | Total Serotype included in Prevnar 13 | 66.7 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 3 | Serotype not included in Prevnar 13:6C | 0.0 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 3 | Serotype not included in Prevnar 13:12 | 0.0 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 3 | Serotype not included in Prevnar 13:15A | 0.0 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 3 | Serotype not included in Prevnar 13:15B | 0.0 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 3 | Serotype not included in Prevnar 13:15F | 0.0 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 3 | Serotype not included in Prevnar 13:21 | 0.0 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Mastoiditis Sample at Surveillance Year 3 | Serotype not included in Prevnar 13:22F | 11.1 percentage of isolates |
Primary
Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 1
The distribution of S pneumoniae serotypes isolated from MEF samples from children in the target population for vaccination over the surveillance year 1 were presented. The percentage of isolates of S pneumoniae serotypes included in Prevnar 13 (3, 7F, 19A, 19F) and not included in Prevnar 13 (6C, 7C, 9N, 10, 11, 12, 12F, 13, 15A, 15B, 15C, 15F, 16, 17, 20, 21, 22F, 23A, 23B, 31, 33A, 33F, 34, 35B, 35F, 38) along with total (both included and not included), clumps and missing or non-viable were computed along with exact 2-sided 95 percent (%) confidence interval (CI) based on the observed proportion of isolates. Missing or non-viable included isolates that were either not sent from an external laboratory, were non-viable or lost on culture prior to sending, or were non-viable on receipt in the central laboratory.'Number of isolates analyzed' signifies total number of isolates that were evaluable for this outcome measure (OM).
Time frame: Surveillance Year 1
Population: MEF population included all participants who have at least 1 S pneumoniae isolate from MEF samples. N (number of participants analyzed) includes total number of participants in MEF population, however actual 'N' for this OM is unknown as this data were not calculated as per planned analysis.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 1 | Serotype not included in Prevnar 13:15A | 3.7 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 1 | Serotype not included in Prevnar 13:38 | 0.7 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 1 | Total Serotype not included in Prevnar 13 | 56.3 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 1 | Serotype clumps | 1.5 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 1 | Serotype included in Prevnar 13:3 | 5.9 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 1 | Serotype included in Prevnar 13:7F | 0.7 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 1 | Serotype included in Prevnar 13:19A | 31.9 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 1 | Serotype included in Prevnar 13:19F | 2.2 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 1 | Total Serotype included in Prevnar 13 | 40.7 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 1 | Serotype not included in Prevnar 13:6C | 6.7 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 1 | Serotype not included in Prevnar 13:7C | 1.5 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 1 | Serotype not included in Prevnar 13:9N | 2.2 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 1 | Serotype not included in Prevnar 13:10 | 3.7 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 1 | Serotype not included in Prevnar 13:11 | 3.7 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 1 | Serotype not included in Prevnar 13:12 | 0.7 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 1 | Serotype not included in Prevnar 13:12F | 0.0 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 1 | Serotype not included in Prevnar 13:13 | 0.7 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 1 | Serotype not included in Prevnar 13:15B | 4.4 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 1 | Serotype not included in Prevnar 13:15C | 3.7 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 1 | Serotype not included in Prevnar 13:15F | 0.0 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 1 | Serotype not included in Prevnar 13:16 | 1.5 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 1 | Serotype not included in Prevnar 13:17 | 0.0 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 1 | Serotype not included in Prevnar 13:20 | 0.0 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 1 | Serotype not included in Prevnar 13:21 | 3.0 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 1 | Serotype not included in Prevnar 13:22F | 1.5 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 1 | Serotype not included in Prevnar 13:23A | 3.7 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 1 | Serotype not included in Prevnar 13:23B | 2.2 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 1 | Serotype not included in Prevnar 13:31 | 2.2 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 1 | Serotype not included in Prevnar 13:33A | 0.7 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 1 | Serotype not included in Prevnar 13:33F | 3.0 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 1 | Serotype not included in Prevnar 13:34 | 0.0 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 1 | Serotype not included in Prevnar 13:35B | 6.7 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 1 | Serotype not included in Prevnar 13:35F | 0.0 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 1 | Serotype Missing/non-viable | 1.5 percentage of isolates |
Primary
Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 2
The distribution of S pneumoniae serotypes isolated from MEF samples from children in the target population for vaccination over the surveillance year 2 were presented. The percentage of isolates of S pneumoniae serotypes included in Prevnar 13 (3, 7F, 19A, 19F) and not included in Prevnar 13 (6C, 7C, 9N, 10, 11, 12, 12F, 13, 15A, 15B, 15C, 15F, 16, 17, 20, 21, 22F, 23A, 23B, 31, 33A, 33F, 34, 35B, 35F, 38) along with total (both included and not included), clumps and missing or non-viable were computed along with exact 2-sided 95% CI based on the observed proportion of isolates. Missing or non-viable included isolates that were either not sent from an external laboratory, were non-viable or lost on culture prior to sending, or were non-viable on receipt in the central laboratory.'Number of isolates analyzed' signifies total number of isolates that were evaluable for this OM.
Time frame: Surveillance Year 2
Population: MEF population included all participants who have at least 1 S pneumoniae isolate from MEF samples. N (number of participants analyzed) includes total number of participants in MEF population, however actual 'N' for this OM is unknown as this data were not calculated as per planned analysis.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 2 | Serotype not included in Prevnar 13:12F | 0.9 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 2 | Serotype included in Prevnar 13:3 | 6.3 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 2 | Serotype included in Prevnar 13:7F | 0.0 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 2 | Serotype included in Prevnar 13:19A | 23.4 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 2 | Serotype included in Prevnar 13:19F | 1.8 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 2 | Total Serotype included in Prevnar 13 | 31.5 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 2 | Serotype not included in Prevnar 13:6C | 4.5 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 2 | Serotype not included in Prevnar 13:7C | 0.9 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 2 | Serotype not included in Prevnar 13:9N | 0.0 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 2 | Serotype not included in Prevnar 13:10 | 0.9 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 2 | Serotype not included in Prevnar 13:11 | 7.2 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 2 | Serotype not included in Prevnar 13:12 | 0.0 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 2 | Serotype not included in Prevnar 13:13 | 0.0 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 2 | Serotype not included in Prevnar 13:15A | 0.9 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 2 | Serotype not included in Prevnar 13:15B | 4.5 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 2 | Serotype not included in Prevnar 13:15C | 2.7 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 2 | Serotype not included in Prevnar 13:15F | 0.0 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 2 | Serotype not included in Prevnar 13:16 | 2.7 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 2 | Serotype not included in Prevnar 13:17 | 1.8 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 2 | Serotype not included in Prevnar 13:20 | 0.0 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 2 | Serotype not included in Prevnar 13:21 | 9.0 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 2 | Serotype not included in Prevnar 13:22F | 0.9 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 2 | Serotype not included in Prevnar 13:23A | 4.5 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 2 | Serotype not included in Prevnar 13:23B | 7.2 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 2 | Serotype not included in Prevnar 13:31 | 1.8 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 2 | Serotype not included in Prevnar 13:33A | 0.0 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 2 | Serotype not included in Prevnar 13:33F | 0.0 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 2 | Serotype not included in Prevnar 13:34 | 0.9 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 2 | Serotype not included in Prevnar 13:35B | 13.5 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 2 | Serotype not included in Prevnar 13:35F | 0.9 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 2 | Serotype not included in Prevnar 13:38 | 0.9 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 2 | Total Serotype not included in Prevnar 13 | 66.7 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 2 | Serotype clumps | 0.9 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 2 | Serotype Missing/non-viable | 0.9 percentage of isolates |
Primary
Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 3
The distribution of S pneumoniae serotypes isolated from MEF samples from children in the target population for vaccination over the surveillance year 3 were presented. The percentage of isolates of S pneumoniae serotypes included in Prevnar 13 (3, 7F, 19A, 19F) and not included in Prevnar 13 (6C, 7C, 9N, 10, 11, 12, 12F, 13, 15A, 15B, 15C, 15F, 16, 17, 20, 21, 22F, 23A, 23B, 31, 33A, 33F, 34, 35B, 35F, 38) along with total (both included and not included), clumps and missing or non-viable were computed along with exact 2-sided 95% CI based on the observed proportion of isolates. Missing or non-viable included isolates that were either not sent from an external laboratory, were non-viable or lost on culture prior to sending, or were non-viable on receipt in the central laboratory.'Number of isolates analyzed' signifies total number of isolates that were evaluable for this OM.
Time frame: Surveillance Year 3
Population: MEF population included all participants who have at least 1 S pneumoniae isolate from MEF samples. N (number of participants analyzed) includes total number of participants in MEF population, however actual 'N' for this OM is unknown as this data were not calculated as per planned analysis.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 3 | Serotype included in Prevnar 13:3 | 7.2 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 3 | Serotype included in Prevnar 13:7F | 0.0 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 3 | Serotype included in Prevnar 13:19A | 9.9 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 3 | Serotype included in Prevnar 13:19F | 6.3 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 3 | Total Serotype included in Prevnar 13 | 23.4 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 3 | Serotype not included in Prevnar 13:6C | 1.8 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 3 | Serotype not included in Prevnar 13:7C | 0.0 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 3 | Serotype not included in Prevnar 13:9N | 0.9 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 3 | Serotype not included in Prevnar 13:10 | 2.7 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 3 | Serotype not included in Prevnar 13:11 | 3.6 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 3 | Serotype not included in Prevnar 13:12 | 0.0 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 3 | Serotype not included in Prevnar 13:12F | 0.0 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 3 | Serotype not included in Prevnar 13:13 | 0.0 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 3 | Serotype not included in Prevnar 13:15A | 6.3 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 3 | Serotype not included in Prevnar 13:15B | 5.4 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 3 | Serotype not included in Prevnar 13:15C | 5.4 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 3 | Serotype not included in Prevnar 13:15F | 0.9 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 3 | Serotype not included in Prevnar 13:16 | 5.4 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 3 | Serotype not included in Prevnar 13:17 | 0.9 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 3 | Serotype not included in Prevnar 13:20 | 0.9 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 3 | Serotype not included in Prevnar 13:21 | 5.4 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 3 | Serotype not included in Prevnar 13:22F | 2.7 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 3 | Serotype not included in Prevnar 13:23A | 2.7 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 3 | Serotype not included in Prevnar 13:23B | 8.1 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 3 | Serotype not included in Prevnar 13:31 | 4.5 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 3 | Serotype not included in Prevnar 13:33A | 0.0 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 3 | Serotype not included in Prevnar 13:33F | 1.8 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 3 | Serotype not included in Prevnar 13:34 | 0.9 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 3 | Serotype not included in Prevnar 13:35B | 10.8 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 3 | Serotype not included in Prevnar 13:35F | 1.8 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 3 | Serotype not included in Prevnar 13:38 | 1.8 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 3 | Total Serotype not included in Prevnar 13 | 74.8 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 3 | Serotype clumps | 0.0 percentage of isolates |
| MEF Population | Percentage of Streptococcus Pneumoniae Serotype Isolates From Middle Ear Fluid (MEF) Sample at Surveillance Year 3 | Serotype Missing/non-viable | 1.8 percentage of isolates |
Secondary
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population
Antimicrobial susceptibility of S pneumoniae isolates for amoxicillin from MEF samples was categorized as resistant, susceptible or intermediate based on minimum inhibitory concentration (MIC) for each serotype at each year of the whole surveillance period. The percentage of S pneumoniae serotypes included 3, 6C, 7C, 9N, 10, 11, 12, 12F, 13, 15A, 15B, 15C, 15F, 16, 17, 19 A, 19 F, 20, 21, 22F, 23A, 23B, 31, 33A, 33F, 34, 35B, 35F, 38, clumps and missing or non-viable, which were to be computed along with exact 2-sided 95% CI based on the observed proportion of isolates. Missing or non-viable included isolates that were either not sent from an external laboratory, were non-viable or lost on culture prior to sending, or were non-viable on receipt in the central laboratory.'Number of isolates analyzed' signifies total number of isolates that were evaluable for this OM.
Time frame: Surveillance Year 1, 2, 3
Population: MEF population. N (number of participants analyzed) includes total number of participants in MEF population, however actual 'N' for this OM is unknown as this data were not calculated as per planned analysis and number analyzed = number of isolates for the given serotype at specified time point.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 3 at Year 1:S | 3.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 6C at Year 1:S | 3.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 7C at Year 1:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 9N at Year 1:S | 0.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 10 at Year 1:S | 1.5 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 11 at Year 1:S | 1.5 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 12 at Year 1:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 12F at Year 1:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 13 at Year 1:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 15A at Year 1:S | 1.5 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 15B at Year 1:S | 0.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 15C at Year 1:S | 3.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 15F at Year 1:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 16 at Year 1:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 17 at Year 1:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 19A at Year 1:S | 3.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 19F at Year 1:S | 0.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 20 at Year 1:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 21 at Year 1:S | 1.5 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 22F at Year 1:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 23A at Year 1:S | 1.5 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 23B at Year 1:S | 0.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 31 at Year 1:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 33A at Year 1:S | 0.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 33F at Year 1:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 34 at Year 1:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 35B at Year 1:S | 3.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 35F at Year 1:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 38 at Year 1:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype clumps at Year 1:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype Missing/non-viable at Year 1:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 3 at Year 2:S | 1.8 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 6C at Year 2:S | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 7C at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 9N at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 10 at Year 2:S | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 11 at Year 2:S | 2.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 12 at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 12F at Year 2:S | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 13 at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 15A at Year 2:S | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 15B at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 15C at Year 2:S | 2.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 15F at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 16 at Year 2:S | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 17 at Year 2:S | 1.8 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 19A at Year 2:S | 1.8 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 19F at Year 2:S | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 20 at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 21 at Year 2:S | 2.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 22F at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 23A at Year 2:S | 2.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 23B at Year 2:S | 2.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 31 at Year 2:S | 1.8 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 33A at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 33F at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 34 at Year 2:S | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 35B at Year 2:S | 4.5 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 35F at Year 2:S | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 38 at Year 2:S | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype clumps at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype Missing/non-viable at Year 2:S | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 3 at Year 3:S | 3.6 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 6C at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 7C at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 9N at Year 3:S | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 10 at Year 3:S | 1.8 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 11 at Year 3:S | 1.8 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 12 at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 12F at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 13 at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 15A at Year 3:S | 2.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 15B at Year 3:S | 3.6 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 15C at Year 3:S | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 15F at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 16 at Year 3:S | 3.6 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 17 at Year 3:S | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 19A at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 19F at Year 3:S | 1.8 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 20 at Year 3:S | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 21 at Year 3:S | 1.8 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 22F at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 23A at Year 3:S | 2.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 23B at Year 3:S | 6.3 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 31 at Year 3:S | 1.8 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 33A at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 33F at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 34 at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 35B at Year 3:S | 5.4 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 35F at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 38 at Year 3:S | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype clumps at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype Missing/non-viable at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 3 at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 6C at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 7C at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 9N at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 10 at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 11 at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 12 at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 12F at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 13 at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 15A at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 15B at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 15C at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 15F at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 16 at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 17 at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 19A at Year 1:I | 5.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 19F at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 20 at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 21 at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 22F at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 23A at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 23B at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 31 at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 33A at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 33F at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 34 at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 35B at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 35F at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 38 at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype clumps at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype Missing/non-viable at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 3 at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 6C at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 7C at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 9N at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 10 at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 11 at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 12 at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 12F at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 13 at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 15A at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 15B at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 15C at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 15F at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 16 at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 17 at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 19A at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 19F at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 20 at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 21 at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 22F at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 23A at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 23B at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 31 at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 33A at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 33F at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 34 at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 35B at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 35F at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 38 at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype clumps at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype Missing/non-viable at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 3 at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 6C at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 7C at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 9N at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 10 at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 11 at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 12 at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 12F at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 13 at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 15A at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 15B at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 15C at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 15F at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 16 at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 17 at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 19A at Year 3:I | 2.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 19F at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 20 at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 21 at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 22F at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 23A at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 23B at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 31 at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 33A at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 33F at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 34 at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 35B at Year 3:I | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 35F at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 38 at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype clumps at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype Missing/non-viable at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 3 at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 6C at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 7C at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 9N at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 10 at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 11 at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 12 at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 12F at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 13 at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 15A at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 15B at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 15C at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 15F at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 16 at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 17 at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 19A at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 19F at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 20 at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 21 at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 22F at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 23A at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 23B at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 31 at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 33A at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 33F at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 34 at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 35B at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 35F at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 38 at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype clumps at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype Missing/non-viable at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 3 at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 6C at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 7C at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 9N at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 10 at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 11 at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 12 at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 12F at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 13 at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 15A at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 15B at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 15C at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 15F at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 16 at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 17 at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 19A at Year 2:R | 1.8 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 19F at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 20 at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 21 at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 22F at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 23A at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 23B at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 31 at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 33A at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 33F at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 34 at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 35B at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 35F at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 38 at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype clumps at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype Missing/non-viable at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 3 at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 6C at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 7C at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 9N at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 10 at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 11 at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 12 at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 12F at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 13 at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 15A at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 15B at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 15C at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 15F at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 16 at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 17 at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 19A at Year 3:R | 2.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 19F at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 20 at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 21 at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 22F at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 23A at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 23B at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 31 at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 33A at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 33F at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 34 at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 35B at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 35F at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype 38 at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype clumps at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Amoxicillin: Middle Ear Fluid (MEF) Population | Serotype Missing/non-viable at Year 3:R | 0.0 percentage of isolates |
Secondary
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population
Antimicrobial susceptibility of S pneumoniae isolates for cefotaxime from MEF samples was categorized as resistant, susceptible or intermediate based on MIC for each serotype at each year of the whole surveillance period. The percentage of S pneumoniae serotypes included 3, 6C, 7C, 9N, 10, 11, 12, 12F, 13, 15A, 15B, 15C, 15F, 16, 17, 19 A, 19 F, 20, 21, 22F, 23A, 23B, 31, 33A, 33F, 34, 35B, 35F, 38, clumps and missing or non-viable, which were to be computed along with exact 2-sided 95% CI based on the observed proportion of isolates. Missing or non-viable included isolates that were either not sent from an external laboratory, were non-viable or lost on culture prior to sending, or were non-viable on receipt in the central laboratory.'Number of isolates analyzed' signifies total number of isolates that were evaluable for this OM.
Time frame: Surveillance Year 1, 2, 3
Population: MEF population. N (number of participants analyzed) includes total number of participants in MEF population, however actual 'N' for this OM is unknown as this data were not calculated as per planned analysis and number analyzed=number of isolates for the given serotype at specified time point.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 21 at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 22F at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 9N at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 10 at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 11 at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 20 at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 3 at Year 1:S | 1.5 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 6C at Year 1:S | 2.2 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 7C at Year 1:S | 0.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 9N at Year 1:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 10 at Year 1:S | 0.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 11 at Year 1:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 12 at Year 1:S | 0.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 12F at Year 1:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 13 at Year 1:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 15A at Year 1:S | 2.2 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 15B at Year 1:S | 2.2 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 15C at Year 1:S | 0.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 15F at Year 1:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 16 at Year 1:S | 0.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 17 at Year 1:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 19A at Year 1:S | 5.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 19F at Year 1:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 20 at Year 1:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 21 at Year 1:S | 0.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 22F at Year 1:S | 0.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 23A at Year 1:S | 0.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 23B at Year 1:S | 0.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 31 at Year 1:S | 2.2 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 33A at Year 1:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 33F at Year 1:S | 2.2 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 34 at Year 1:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 35B at Year 1:S | 3.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 35F at Year 1:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 38 at Year 1:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype clumps at Year 1:S | 1.5 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype Missing/non-viable at Year 1:S | 0.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 3 at Year 2:S | 2.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 6C at Year 2:S | 1.8 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 7C at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 9N at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 10 at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 11 at Year 2:S | 2.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 12 at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 12F at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 13 at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 15A at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 15B at Year 2:S | 2.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 15C at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 15F at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 16 at Year 2:S | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 17 at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 19A at Year 2:S | 2.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 19F at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 20 at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 21 at Year 2:S | 4.5 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 22F at Year 2:S | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 23A at Year 2:S | 1.8 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 23B at Year 2:S | 2.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 31 at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 33A at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 33F at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 34 at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 35B at Year 2:S | 4.5 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 35F at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 38 at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype clumps at Year 2:S | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype Missing/non-viable at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 3 at Year 3:S | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 6C at Year 3:S | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 7C at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 9N at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 10 at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 11 at Year 3:S | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 12 at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 12F at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 13 at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 15A at Year 3:S | 1.8 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 15B at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 15C at Year 3:S | 2.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 15F at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 16 at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 17 at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 19A at Year 3:S | 1.8 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 19F at Year 3:S | 2.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 20 at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 21 at Year 3:S | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 22F at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 23A at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 23B at Year 3:S | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 31 at Year 3:S | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 33A at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 33F at Year 3:S | 1.8 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 34 at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 35B at Year 3:S | 2.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 35F at Year 3:S | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 38 at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype clumps at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype Missing/non-viable at Year 3:S | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 3 at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 6C at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 7C at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 9N at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 10 at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 11 at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 12 at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 12F at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 13 at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 15A at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 15B at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 15C at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 15F at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 16 at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 17 at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 19A at Year 1:I | 7.4 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 19F at Year 1:I | 0.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 20 at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 21 at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 22F at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 23A at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 23B at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 31 at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 33A at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 33F at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 34 at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 35B at Year 1:I | 0.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 35F at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 17 at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 19A at Year 2:I | 4.5 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 19F at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 20 at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 21 at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 22F at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 23A at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 23B at Year 2:I | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 31 at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 33A at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 33F at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 34 at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 35B at Year 2:I | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 35F at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 38 at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype clumps at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype Missing/non-viable at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 3 at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 6C at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 7C at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 9N at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 10 at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 11 at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 12 at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 12F at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 13 at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 31 at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 15A at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 15B at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 15C at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 15F at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 16 at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 17 at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 19A at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 19F at Year 3:I | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 20 at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 35F at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 21 at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 22F at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 23A at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 23B at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 33A at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 33F at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 34 at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 35B at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 38 at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype clumps at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype Missing/non-viable at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 3 at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 6C at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 7C at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 9N at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 10 at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 11 at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 12 at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 12F at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 13 at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 15A at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 15B at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 15C at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 15F at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 16 at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 17 at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 19A at Year 1:R | 1.5 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 19F at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 20 at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 21 at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 22F at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 23A at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 23B at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 31 at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 33A at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 33F at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 34 at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 35B at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 35F at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 38 at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype clumps at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype Missing/non-viable at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 3 at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 6C at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 7C at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 9N at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 10 at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 11 at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 12 at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 38 at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype clumps at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype Missing/non-viable at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 3 at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 6C at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 7C at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 9N at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 10 at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 11 at Year 2:I | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 12 at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 12F at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 13 at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 15A at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 15B at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 15C at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 15F at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 16 at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 12F at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 13 at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 15A at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 15B at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 15C at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 15F at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 16 at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 17 at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 19A at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 19F at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 20 at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 23A at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 23B at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 31 at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 33A at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 33F at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 34 at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 35B at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 35F at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 38 at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype clumps at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype Missing/non-viable at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 3 at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 6C at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 7C at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 12 at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 12F at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 13 at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 15A at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 15B at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 15C at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 15F at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 16 at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 17 at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 19A at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 19F at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 21 at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 22F at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 23A at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 23B at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 31 at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 33A at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 33F at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 34 at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 35B at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 35F at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype 38 at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype clumps at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Cefotaxime: Middle Ear Fluid (MEF) Population | Serotype Missing/non-viable at Year 3:R | 0.0 percentage of isolates |
Secondary
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population
Antimicrobial susceptibility of S pneumoniae isolates for ceftriaxone from mastoid samples was categorized as resistant, susceptible or intermediate based on MIC for each serotype at each year of the whole surveillance period. The percentage of S pneumoniae serotypes included 3, 12, 15A, 15B, 15F, 19A, 19F, 21, 22F, 23A, 38, which were to be computed along with exact 2-sided 95% CI based on the observed proportion of isolates. 'Number of isolates analyzed' signifies total number of isolates that were evaluable for this OM.
Time frame: Surveillance Year 1, 2, 3
Population: Mastoid population. N (number of participants analyzed) includes total number of participants in mastoid population, however actual 'N' for this OM is unknown as this data were not calculated as per planned analysis and number analyzed=number of isolates for the given serotype at specified time point.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population | Serotype 3 at Year 1:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population | Serotype 12 at Year 1:S | 5.6 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population | Serotype 15A at Year 1:S | 5.6 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population | Serotype 15B at Year 1:S | 5.6 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population | Serotype 15F at Year 1:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population | Serotype 19A at Year 1:S | 27.8 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population | Serotype 19F at Year 1:S | 11.1 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population | Serotype 21 at Year 1:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population | Serotype 22F at Year 1:S | 11.1 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population | Serotype 23A at Year 1:S | 5.6 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population | Serotype 38 at Year 1:S | 5.6 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population | Serotype 3 at Year 2:S | 28.6 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population | Serotype 12 at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population | Serotype 15A at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population | Serotype 15B at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population | Serotype 15F at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population | Serotype 19A at Year 2:S | 57.1 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population | Serotype 19F at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population | Serotype 21 at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population | Serotype 22F at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population | Serotype 23A at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population | Serotype 38 at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population | Serotype 3 at Year 3:S | 44.4 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population | Serotype 12 at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population | Serotype 15A at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population | Serotype 15B at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population | Serotype 15F at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population | Serotype 19A at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population | Serotype 19F at Year 3:S | 11.1 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population | Serotype 21 at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population | Serotype 22F at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population | Serotype 23A at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population | Serotype 38 at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population | Serotype 3 at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population | Serotype 12 at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population | Serotype 15A at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population | Serotype 15B at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population | Serotype 15F at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population | Serotype 19A at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population | Serotype 19F at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population | Serotype 21 at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population | Serotype 22F at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population | Serotype 23A at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population | Serotype 38 at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population | Serotype 3 at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population | Serotype 12 at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population | Serotype 15A at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population | Serotype 15B at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population | Serotype 15F at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population | Serotype 19A at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population | Serotype 19F at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population | Serotype 21 at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population | Serotype 22F at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population | Serotype 23A at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population | Serotype 38 at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population | Serotype 3 at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population | Serotype 12 at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population | Serotype 15A at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population | Serotype 15B at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population | Serotype 15F at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population | Serotype 19A at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population | Serotype 19F at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population | Serotype 21 at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population | Serotype 22F at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population | Serotype 23A at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population | Serotype 38 at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population | Serotype 3 at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population | Serotype 12 at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population | Serotype 15A at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population | Serotype 15B at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population | Serotype 15F at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population | Serotype 19A at Year 1:R | 5.6 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population | Serotype 19F at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population | Serotype 21 at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population | Serotype 22F at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population | Serotype 23A at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population | Serotype 38 at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population | Serotype 3 at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population | Serotype 12 at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population | Serotype 15A at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population | Serotype 15B at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population | Serotype 15F at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population | Serotype 19A at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population | Serotype 19F at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population | Serotype 21 at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population | Serotype 22F at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population | Serotype 23A at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population | Serotype 38 at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population | Serotype 3 at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population | Serotype 12 at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population | Serotype 15A at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population | Serotype 15B at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population | Serotype 15F at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population | Serotype 19A at Year 3:R | 11.1 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population | Serotype 19F at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population | Serotype 21 at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population | Serotype 22F at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population | Serotype 23A at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Mastoid Population | Serotype 38 at Year 3:R | 0.0 percentage of isolates |
Secondary
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population
Antimicrobial susceptibility of S pneumoniae isolates for ceftriaxone from MEF samples was categorized as resistant, susceptible or intermediate based on MIC for each serotype at each year of the whole surveillance period. The percentage of S pneumoniae serotypes included 3, 6C, 7C, 9N, 10, 11, 12, 12F, 13, 15A, 15B, 15C, 15F, 16, 17, 19 A, 19 F, 20, 21, 22F, 23A, 23B, 31, 33A, 33F, 34, 35B, 35F, 38, clumps and missing or non-viable, which were to be computed along with exact 2-sided 95% CI based on the observed proportion of isolates. Missing or non-viable included isolates that were either not sent from an external laboratory, were non-viable or lost on culture prior to sending, or were non-viable on receipt in the central laboratory.'Number of isolates analyzed' signifies total number of isolates that were evaluable for this OM.
Time frame: Surveillance Year 1, 2, 3
Population: MEF population. N (number of participants analyzed) includes total number of participants in MEF population, however actual 'N' for this OM is unknown as this data were not calculated as per planned analysis and n=number of isolates for the given serotype at specified time point.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 16 at Year 1:S | 1.5 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 22F at Year 1:S | 1.5 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 11 at Year 3:S | 3.6 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 15C at Year 3:S | 5.4 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 20 at Year 3:S | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 31 at Year 3:S | 4.5 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 35F at Year 3:S | 1.8 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 6C at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 12 at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 15F at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 21 at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 35F at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 7C at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 12F at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 15C at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 17 at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 22F at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 15C at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype clumps at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 10 at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 35F at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 33A at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 3 at Year 1:S | 5.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 6C at Year 1:S | 6.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 7C at Year 1:S | 1.5 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 9N at Year 1:S | 2.2 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 10 at Year 1:S | 3.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 11 at Year 1:S | 3.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 12 at Year 1:S | 0.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 12F at Year 1:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 13 at Year 1:S | 0.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 15A at Year 1:S | 3.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 15B at Year 1:S | 4.4 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 15C at Year 1:S | 3.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 15F at Year 1:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 17 at Year 1:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 19A at Year 1:S | 20.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 19F at Year 1:S | 1.5 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 20 at Year 1:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 21 at Year 1:S | 3.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 23A at Year 1:S | 3.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 23B at Year 1:S | 0.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 31 at Year 1:S | 2.2 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 33A at Year 1:S | 0.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 33F at Year 1:S | 3.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 34 at Year 1:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 35B at Year 1:S | 6.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 35F at Year 1:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 38 at Year 1:S | 0.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype clumps at Year 1:S | 0.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype Missing/non-viable at Year 1:S | 0.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 3 at Year 2:S | 6.3 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 6C at Year 2:S | 3.6 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 7C at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 9N at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 10 at Year 2:S | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 11 at Year 2:S | 6.3 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 12 at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 12F at Year 2:S | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 13 at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 15A at Year 2:S | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 15B at Year 2:S | 3.6 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 15C at Year 2:S | 2.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 15F at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 16 at Year 2:S | 2.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 17 at Year 2:S | 1.8 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 19A at Year 2:S | 13.5 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 19F at Year 2:S | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 20 at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 21 at Year 2:S | 9.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 22F at Year 2:S | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 23A at Year 2:S | 4.5 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 23B at Year 2:S | 6.3 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 31 at Year 2:S | 1.8 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 33A at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 33F at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 34 at Year 2:S | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 35B at Year 2:S | 11.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 35F at Year 2:S | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 38 at Year 2:S | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype clumps at Year 2:S | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype Missing/non-viable at Year 2:S | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 3 at Year 3:S | 6.3 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 6C at Year 3:S | 1.8 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 7C at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 9N at Year 3:S | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 10 at Year 3:S | 2.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 12 at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 12F at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 13 at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 15A at Year 3:S | 6.3 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 15B at Year 3:S | 4.5 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 15F at Year 3:S | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 16 at Year 3:S | 4.5 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 17 at Year 3:S | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 19A at Year 3:S | 5.4 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 19F at Year 3:S | 4.5 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 21 at Year 3:S | 5.4 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 22F at Year 3:S | 1.8 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 23A at Year 3:S | 2.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 23B at Year 3:S | 8.1 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 33A at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 33F at Year 3:S | 1.8 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 34 at Year 3:S | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 35B at Year 3:S | 9.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 38 at Year 3:S | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype clumps at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype Missing/non-viable at Year 3:S | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 3 at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 7C at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 9N at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 10 at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 11 at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 12F at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 13 at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 15A at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 15B at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 15C at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 16 at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 17 at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 19A at Year 1:I | 8.1 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 19F at Year 1:I | 0.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 20 at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 22F at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 23A at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 23B at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 31 at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 33A at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 33F at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 34 at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 35B at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 38 at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype clumps at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype Missing/non-viable at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 3 at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 6C at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 9N at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 10 at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 11 at Year 2:I | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 12 at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 13 at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 15A at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 15B at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 15F at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 16 at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 19A at Year 2:I | 7.2 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 19F at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 20 at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 21 at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 23A at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 23B at Year 2:I | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 31 at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 33A at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 33F at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 34 at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 35B at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 35F at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 38 at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype clumps at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype Missing/non-viable at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 3 at Year 3:I | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 6C at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 7C at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 9N at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 10 at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 11 at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 12 at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 12F at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 13 at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 15A at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 15B at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 15F at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 16 at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 17 at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 19A at Year 3:I | 2.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 19F at Year 3:I | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 20 at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 21 at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 22F at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 23A at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 23B at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 31 at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 33A at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 33F at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 34 at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 35B at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 35F at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 38 at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype Missing/non-viable at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 3 at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 6C at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 7C at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 9N at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 10 at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 11 at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 12 at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 12F at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 13 at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 15A at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 15B at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 15C at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 15F at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 16 at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 17 at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 19A at Year 1:R | 1.5 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 19F at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 20 at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 21 at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 22F at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 23A at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 23B at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 31 at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 33A at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 33F at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 34 at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 35B at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 35F at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 38 at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype clumps at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype Missing/non-viable at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 3 at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 6C at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 7C at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 9N at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 11 at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 12 at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 12F at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 13 at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 15A at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 15B at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 15C at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 15F at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 16 at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 17 at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 19A at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 19F at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 20 at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 21 at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 22F at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 23A at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 23B at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 31 at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 33A at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 33F at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 34 at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 35B at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 38 at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype clumps at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype Missing/non-viable at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 3 at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 6C at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 7C at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 9N at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 10 at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 11 at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 12 at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 12F at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 13 at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 15A at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 15B at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 15C at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 15F at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 16 at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 17 at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 19A at Year 3:R | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 19F at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 20 at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 21 at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 22F at Year 3:R | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 23A at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 23B at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 31 at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 33F at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 34 at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 35B at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 35F at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype 38 at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype clumps at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Ceftriaxone: Middle Ear Fluid (MEF) Population | Serotype Missing/non-viable at Year 3:R | 0.0 percentage of isolates |
Secondary
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population
Antimicrobial susceptibility of S pneumoniae isolates for clindamycin from mastoid samples was categorized as resistant, susceptible or intermediate based on MIC for each serotype at each year of the whole surveillance period. The percentage of S pneumoniae serotypes included 3, 12, 15A, 15B, 15F, 19A, 19F, 21, 22F, 23A, 38, which were to be computed along with exact 2-sided 95% CI based on the observed proportion of isolates. 'Number of isolates analyzed' signifies total number of isolates that were evaluable for this OM.
Time frame: Surveillance Year 1, 2, 3
Population: Mastoid population. N (number of participants analyzed) includes total number of participants in mastoid population, however actual 'N' for this OM is unknown as this data were not calculated as per planned analysis and number analyzed=number of isolates for the given serotype at specified time point.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population | Serotype 3 at Year 1:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population | Serotype 15F at Year 1:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population | Serotype 19A at Year 1:S | 5.6 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population | Serotype 19F at Year 1:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population | Serotype 21 at Year 1:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population | Serotype 22F at Year 1:S | 5.6 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population | Serotype 23A at Year 1:S | 5.6 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population | Serotype 38 at Year 1:S | 5.6 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population | Serotype 3 at Year 2:S | 28.6 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population | Serotype 12 at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population | Serotype 15A at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population | Serotype 15B at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population | Serotype 15F at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population | Serotype 19A at Year 2:S | 28.6 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population | Serotype 19F at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population | Serotype 21 at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population | Serotype 22F at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population | Serotype 23A at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population | Serotype 38 at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population | Serotype 3 at Year 3:S | 22.2 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population | Serotype 12 at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population | Serotype 15A at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population | Serotype 15B at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population | Serotype 15F at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population | Serotype 19A at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population | Serotype 19F at Year 3:S | 11.1 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population | Serotype 21 at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population | Serotype 22F at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population | Serotype 23A at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population | Serotype 38 at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population | Serotype 3 at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population | Serotype 12 at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population | Serotype 15A at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population | Serotype 15B at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population | Serotype 15F at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population | Serotype 19A at Year 1:I | 5.6 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population | Serotype 19F at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population | Serotype 21 at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population | Serotype 22F at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population | Serotype 23A at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population | Serotype 38 at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population | Serotype 3 at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population | Serotype 12 at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population | Serotype 15A at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population | Serotype 15B at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population | Serotype 15F at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population | Serotype 19A at Year 2:I | 14.3 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population | Serotype 19F at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population | Serotype 21 at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population | Serotype 22F at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population | Serotype 23A at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population | Serotype 38 at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population | Serotype 3 at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population | Serotype 12 at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population | Serotype 15A at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population | Serotype 15B at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population | Serotype 15F at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population | Serotype 19A at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population | Serotype 19F at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population | Serotype 21 at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population | Serotype 22F at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population | Serotype 23A at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population | Serotype 38 at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population | Serotype 3 at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population | Serotype 12 at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population | Serotype 15A at Year 1:R | 5.6 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population | Serotype 15B at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population | Serotype 15F at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population | Serotype 19A at Year 1:R | 22.2 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population | Serotype 19F at Year 1:R | 5.6 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population | Serotype 21 at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population | Serotype 22F at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population | Serotype 23A at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population | Serotype 38 at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population | Serotype 3 at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population | Serotype 12 at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population | Serotype 15A at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population | Serotype 15B at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population | Serotype 15F at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population | Serotype 19A at Year 2:R | 28.6 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population | Serotype 19F at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population | Serotype 21 at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population | Serotype 22F at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population | Serotype 23A at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population | Serotype 38 at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population | Serotype 3 at Year 3:R | 11.1 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population | Serotype 12 at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population | Serotype 15A at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population | Serotype 15B at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population | Serotype 15F at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population | Serotype 19A at Year 3:R | 11.1 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population | Serotype 19F at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population | Serotype 21 at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population | Serotype 22F at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population | Serotype 23A at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population | Serotype 38 at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population | Serotype 12 at Year 1:S | 5.6 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population | Serotype 15A at Year 1:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Mastoid Population | Serotype 15B at Year 1:S | 5.6 percentage of isolates |
Secondary
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population
Antimicrobial susceptibility of S pneumoniae isolates for clindamycin from MEF samples was categorized as resistant, susceptible or intermediate based on MIC for each serotype at each year of the whole surveillance period. The percentage of S pneumoniae serotypes included 3, 6C, 7C, 9N, 10, 11, 12, 12F, 13, 15A, 15B, 15C, 15F, 16, 17, 19 A, 19 F, 20, 21, 22F, 23A, 23B, 31, 33A, 33F, 34, 35B, 35F, 38, clumps and missing or non-viable, which were to be computed along with exact 2-sided 95% CI based on the observed proportion of isolates. Missing or non-viable included isolates that were either not sent from an external laboratory, were non-viable or lost on culture prior to sending, or were non-viable on receipt in the central laboratory.'Number of isolates analyzed' signifies total number of isolates that were evaluable for this OM.
Time frame: Surveillance Year 1, 2, 3
Population: MEF population. N (number of participants analyzed) includes total number of participants in MEF population, however actual 'N' for this OM is unknown as this data were not calculated as per planned analysis and number analyzed=number of isolates for the given serotype at specified time point.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 15B at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 11 at Year 1:S | 1.5 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 33A at Year 1:S | 0.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 38 at Year 1:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 11 at Year 2:S | 3.6 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 19A at Year 2:S | 2.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 6C at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype Missing/non-viable at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 12F at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 21 at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 34 at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 3 at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 15A at Year 2:R | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 15B at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 15C at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 15F at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 16 at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 19A at Year 2:R | 6.3 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 19F at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 20 at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 22F at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 11 at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 12 at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 12F at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 13 at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 15A at Year 3:R | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 15C at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 15F at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 16 at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 17 at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 19A at Year 3:R | 4.5 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 19F at Year 3:R | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 20 at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 21 at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 38 at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype clumps at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype Missing/non-viable at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 3 at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 6C at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 7C at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 9N at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 3 at Year 1:S | 4.4 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 9N at Year 1:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 10 at Year 1:S | 1.5 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 12 at Year 1:S | 0.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 12F at Year 1:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 13 at Year 1:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 15A at Year 1:S | 0.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 15B at Year 1:S | 2.2 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 15C at Year 1:S | 3.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 15F at Year 1:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 16 at Year 1:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 17 at Year 1:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 19A at Year 1:S | 3.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 19F at Year 1:S | 0.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 20 at Year 1:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 21 at Year 1:S | 1.5 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 22F at Year 1:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 23A at Year 1:S | 2.2 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 23B at Year 1:S | 0.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 31 at Year 1:S | 1.5 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 33F at Year 1:S | 0.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 34 at Year 1:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 35B at Year 1:S | 5.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 35F at Year 1:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype clumps at Year 1:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype Missing/non-viable at Year 1:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 3 at Year 2:S | 4.5 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 6C at Year 2:S | 2.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 7C at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 9N at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 10 at Year 2:S | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 12 at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 12F at Year 2:S | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 13 at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 15A at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 15B at Year 2:S | 1.8 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 15C at Year 2:S | 2.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 15F at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 16 at Year 2:S | 1.8 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 17 at Year 2:S | 1.8 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 19F at Year 2:S | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 20 at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 21 at Year 2:S | 5.4 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 22F at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 23A at Year 2:S | 1.8 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 23B at Year 2:S | 6.3 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 31 at Year 2:S | 1.8 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 33A at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 33F at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 34 at Year 2:S | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 35B at Year 2:S | 9.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 35F at Year 2:S | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 38 at Year 2:S | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype clumps at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype Missing/non-viable at Year 2:S | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 3 at Year 3:S | 3.6 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 6C at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 7C at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 9N at Year 3:S | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 10 at Year 3:S | 1.8 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 11 at Year 3:S | 1.8 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 12 at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 12F at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 13 at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 15A at Year 3:S | 2.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 15B at Year 3:S | 2.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 15C at Year 3:S | 2.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 15F at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 16 at Year 3:S | 3.6 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 17 at Year 3:S | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 19A at Year 3:S | 1.8 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 19F at Year 3:S | 2.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 20 at Year 3:S | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 21 at Year 3:S | 1.8 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 22F at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 23A at Year 3:S | 2.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 23B at Year 3:S | 7.2 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 31 at Year 3:S | 2.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 33A at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 33F at Year 3:S | 1.8 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 34 at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 35B at Year 3:S | 6.3 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 35F at Year 3:S | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 38 at Year 3:S | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype clumps at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype Missing/non-viable at Year 3:S | 1.8 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 6C at Year 1:S | 4.4 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 7C at Year 1:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 3 at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 7C at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 9N at Year 1:I | 0.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 10 at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 11 at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 12 at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 12F at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 13 at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 15A at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 15B at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 15C at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 15F at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 16 at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 17 at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 19A at Year 1:I | 5.2 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 19F at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 20 at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 21 at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 22F at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 23A at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 23B at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 31 at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 33A at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 33F at Year 1:I | 0.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 34 at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 35B at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 35F at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 38 at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype clumps at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 3 at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 6C at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 7C at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 9N at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 10 at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 11 at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 12 at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 12F at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 13 at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 15A at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 15B at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 15C at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 15F at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 16 at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 17 at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 19A at Year 2:I | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 19F at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 20 at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 21 at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 22F at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 23A at Year 2:I | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 23B at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 31 at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 33A at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 33F at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 34 at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 35B at Year 2:I1 | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 35F at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 38 at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype clumps at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype Missing/non-viable at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 3 at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 6C at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 7C at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 9N at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 10 at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 11 at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 12 at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 13 at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 15A at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 15B at Year 3:I | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 15C at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 15F at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 16 at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 17 at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 19A at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 19F at Year 3:I | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 20 at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 22F at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 23A at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 23B at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 31 at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 33A at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 33F at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 34 at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 35B at Year 3:I | 2.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 35F at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 38 at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype clumps at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype Missing/non-viable at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 3 at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 6C at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 7C at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 9N at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 10 at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 11 at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 12 at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 12F at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 13 at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 15A at Year 1:R | 2.2 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 15B at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 15C at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 15F at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 16 at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 17 at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 19A at Year 1:R | 12.6 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 19F at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 20 at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 21 at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 22F at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 23A at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 23B at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 31 at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 33A at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 33F at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 35B at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 35F at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 38 at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype clumps at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype Missing/non-viable at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 6C at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 7C at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 9N at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 10 at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 11 at Year 2:R | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 12 at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 12F at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 13 at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 21 at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 17 at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 22F at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 23A at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 23B at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 31 at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 33A at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 33F at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 34 at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 35B at Year 2:R | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 35F at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype Missing/non-viable at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 10 at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 23A at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 23B at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 31 at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 33A at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 33F at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 34 at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 35B at Year 3:R | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 35F at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype 38 at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Clindamycin: Middle Ear Fluid (MEF) Population | Serotype clumps at Year 3:R | 0.0 percentage of isolates |
Secondary
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population
Antimicrobial susceptibility of S pneumoniae isolates for erythromycin from mastoid samples was categorized as resistant, susceptible or intermediate based on MIC for each serotype at each year of the whole surveillance period. The percentage of S pneumoniae serotypes included 3, 12, 15A, 15B, 15F, 19A, 19F, 21, 22F, 23A, 38, which were to be computed along with exact 2-sided 95% CI based on the observed proportion of isolates. 'Number of isolates analyzed' signifies total number of isolates that were evaluable for this OM.
Time frame: Surveillance Year 1, 2, 3
Population: Mastoid population. N (number of participants analyzed) includes total number of participants in mastoid population, however actual 'N' for this OM is unknown as this data were not calculated as per planned analysis and number analyzed=number of isolates for the given serotype at specified time point.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population | Serotype 3 at Year 1:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population | Serotype 12 at Year 1:S | 5.6 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population | Serotype 15A at Year 1:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population | Serotype 15B at Year 1:S | 5.6 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population | Serotype 15F at Year 1:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population | Serotype 19A at Year 1:S | 5.6 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population | Serotype 19F at Year 1:S | 5.6 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population | Serotype 21 at Year 1:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population | Serotype 22F at Year 1:S | 11.1 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population | Serotype 23A at Year 1:S | 5.6 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population | Serotype 38 at Year 1:S | 5.6 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population | Serotype 3 at Year 2:S | 28.6 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population | Serotype 12 at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population | Serotype 15A at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population | Serotype 15B at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population | Serotype 15F at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population | Serotype 19A at Year 2:S | 28.6 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population | Serotype 19F at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population | Serotype 21 at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population | Serotype 22F at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population | Serotype 23A at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population | Serotype 38 at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population | Serotype 3 at Year 3:S | 33.3 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population | Serotype 12 at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population | Serotype 15A at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population | Serotype 15B at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population | Serotype 15F at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population | Serotype 19A at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population | Serotype 19F at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population | Serotype 21 at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population | Serotype 22F at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population | Serotype 23A at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population | Serotype 38 at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population | Serotype 3 at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population | Serotype 12 at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population | Serotype 15A at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population | Serotype 15B at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population | Serotype 15F at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population | Serotype 19A at Year 1:I | 5.6 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population | Serotype 19F at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population | Serotype 21 at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population | Serotype 22F at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population | Serotype 23A at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population | Serotype 38 at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population | Serotype 3 at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population | Serotype 12 at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population | Serotype 15A at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population | Serotype 15B at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population | Serotype 15F at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population | Serotype 19A at Year 2:I | 14.3 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population | Serotype 19F at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population | Serotype 21 at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population | Serotype 22F at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population | Serotype 23A at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population | Serotype 38 at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population | Serotype 3 at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population | Serotype 12 at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population | Serotype 15A at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population | Serotype 15B at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population | Serotype 15F at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population | Serotype 19A at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population | Serotype 19F at Year 3:I | 11.1 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population | Serotype 21 at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population | Serotype 22F at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population | Serotype 23A at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population | Serotype 38 at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population | Serotype 3 at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population | Serotype 12 at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population | Serotype 15A at Year 1:R | 5.6 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population | Serotype 15B at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population | Serotype 15F at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population | Serotype 19A at Year 1:R | 22.2 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population | Serotype 19F at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population | Serotype 21 at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population | Serotype 22F at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population | Serotype 23A at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population | Serotype 38 at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population | Serotype 3 at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population | Serotype 12 at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population | Serotype 15A at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population | Serotype 15B at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population | Serotype 15F at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population | Serotype 19A at Year 2:R | 28.6 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population | Serotype 19F at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population | Serotype 21 at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population | Serotype 22F at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population | Serotype 23A at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population | Serotype 38 at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population | Serotype 3 at Year 3:R | 11.1 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population | Serotype 12 at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population | Serotype 15A at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population | Serotype 15B at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population | Serotype 15F at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population | Serotype 19A at Year 3:R | 11.1 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population | Serotype 19F at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population | Serotype 21 at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population | Serotype 22F at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population | Serotype 23A at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Mastoid Population | Serotype 38 at Year 3:R | 0.0 percentage of isolates |
Secondary
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population
Antimicrobial susceptibility of S pneumoniae isolates for erythromycin from MEF samples was categorized as resistant, susceptible or intermediate based on MIC for each serotype at each year of the whole surveillance period. The percentage of S pneumoniae serotypes included 3, 6C, 7C, 9N, 10, 11, 12, 12F, 13, 15A, 15B, 15C, 15F, 16, 17, 19A, 19F, 20, 21, 22F, 23A, 23B, 31, 33A, 33F, 34, 35B, 35F, 38, clumps and missing or non-viable, which were to be computed along with exact 2-sided 95% CI based on the observed proportion of isolates. Missing or non-viable included isolates that were either not sent from an external laboratory, were non-viable or lost on culture prior to sending, or were non-viable on receipt in the central laboratory.'Number of isolates analyzed' signifies total number of isolates that were evaluable for this OM.
Time frame: Surveillance Year 1, 2, 3
Population: MEF population. N (number of participants analyzed) includes total number of participants in MEF population, however actual 'N' for this OM is unknown as this data were not calculated as per planned analysis and number analyzed=number of isolates for the given serotype at specified time point.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 9N at Year 3:S | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 3 at Year 1:S | 5.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 6C at Year 1:S | 4.4 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 7C at Year 1:S | 1.5 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 9N at Year 1:S | 2.2 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 10 at Year 1:S | 3.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 11 at Year 1:S | 3.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 12 at Year 1:S | 0.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 12F at Year 1:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 13 at Year 1:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 15A at Year 1:S | 1.5 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 15B at Year 1:S | 3.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 15C at Year 1:S | 1.5 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 15F at Year 1:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 16 at Year 1:S | 1.5 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 17 at Year 1:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 19A at Year 1:S | 1.5 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 19F at Year 1:S | 0.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 20 at Year 1:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 21 at Year 1:S | 3.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 22F at Year 1:S | 1.5 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 23A at Year 1:S | 3.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 23B at Year 1:S | 0.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 31 at Year 1:S | 0.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 33A at Year 1:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 33F at Year 1:S | 0.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 34 at Year 1:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 35B at Year 1:S | 2.2 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 35F at Year 1:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 38 at Year 1:S | 0.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype clumps at Year 1:S | 0.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype Missing/non-viable at Year 1:S | 0.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 3 at Year 2:S | 5.4 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 6C at Year 2:S | 2.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 7C at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 9N at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 10 at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 11 at Year 2:S | 3.6 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 12 at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 12F at Year 2:S | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 13 at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 15A at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 15B at Year 2:S | 1.8 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 15C at Year 2:S | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 15F at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 16 at Year 2:S | 2.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 17 at Year 2:S | 1.8 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 19A at Year 2:S | 3.6 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 19F at Year 2:S | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 20 at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 21 at Year 2:S | 9.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 22F at Year 2:S | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 23A at Year 2:S | 3.6 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 23B at Year 2:S | 5.4 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 31 at Year 2:S | 1.8 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 33A at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 33F at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 34 at Year 2:S | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 35B at Year 2:S | 3.6 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 35F at Year 2:S | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 38 at Year 2:S | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype clumps at Year 2:S | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype Missing/non-viable at Year 2:S | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 3 at Year 3:S | 5.4 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 6C at Year 3:S | 1.8 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 7C at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 10 at Year 3:S | 2.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 11 at Year 3:S | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 12 at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 12F at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 13 at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 15A at Year 3:S | 2.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 15B at Year 3:S | 1.8 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 15C at Year 3:S | 3.6 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 15F at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 16 at Year 3:S | 3.6 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 17 at Year 3:S | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 19A at Year 3:S | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 19F at Year 3:S | 2.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 20 at Year 3:S | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 21 at Year 3:S | 4.5 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 22F at Year 3:S | 1.8 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 23A at Year 3:S | 2.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 23B at Year 3:S | 3.6 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 31 at Year 3:S | 4.5 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 33A at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 33F at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 34 at Year 3:S | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 35B at Year 3:S | 2.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 35F at Year 3:S | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 38 at Year 3:S | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype clumps at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype Missing/non-viable at Year 3:S | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 3 at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 6C at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 7C at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 9N at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 10 at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 11 at Year 1:I | 0.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 12 at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 12F at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 13 at Year 1:I | 0.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 15A at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 15B at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 15C at Year 1:I | 0.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 15F at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 16 at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 17 at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 19A at Year 1:I | 14.1 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 19F at Year 1:I | 0.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 20 at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 21 at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 22F at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 23A at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 23B at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 31 at Year 1:I | 0.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 33A at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 33F at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 34 at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 35B at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 35F at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 38 at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype clumps at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype Missing/non-viable at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 3 at Year 2:I | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 6C at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 7C at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 9N at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 10 at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 11 at Year 2:I | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 12 at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 12F at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 13 at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 15A at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 15B at Year 2:I | 2.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 15C at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 15F at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 16 at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 17 at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 19A at Year 2:I | 12.6 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 19F at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 20 at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 21 at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 22F at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 23A at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 23B at Year 2:I | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 31 at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 33A at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 33F at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 34 at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 35B at Year 2:I | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 35F at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 38 at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype clumps at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype Missing/non-viable at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 3 at Year 3:I | 1.8 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 6C at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 7C at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 9N at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 10 at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 11 at Year 3:I | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 12 at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 12F at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 13 at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 15A at Year 3:I | 2.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 15B at Year 3:I | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 15C at Year 3:I | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 15F at Year 3:I | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 16 at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 17 at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 19A at Year 3:I | 2.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 19F at Year 3:I | 1.8 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 20 at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 21 at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 22F at Year 3:I | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 23A at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 23B at Year 3:I | 1.8 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 31 at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 33A at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 33F at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 34 at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 35B at Year 3:I | 2.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 35F at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 38 at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype clumps at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype Missing/non-viable at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 3 at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 6C at Year 1:R | 2.2 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 7C at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 9N at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 10 at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 11 at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 12 at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 12F at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 13 at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 15A at Year 1:R | 1.5 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 15B at Year 1:R | 0.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 15C at Year 1:R | 1.5 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 15F at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 16 at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 17 at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 19A at Year 1:R | 14.8 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 19F at Year 1:R | 0.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 20 at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 21 at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 22F at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 23A at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 23B at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 31 at Year 1:R | 0.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 33A at Year 1:R | 0.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 33F at Year 1:R | 2.2 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 34 at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 35B at Year 1:R | 4.4 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 35F at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 38 at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype clumps at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype Missing/non-viable at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 3 at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 6C at Year 2:R | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 7C at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 9N at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 10 at Year 2:R | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 11 at Year 2:R | 2.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 12 at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 12F at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 13 at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 15A at Year 2:R | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 15B at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 15C at Year 2:R | 1.8 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 15F at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 16 at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 17 at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 19A at Year 2:R | 6.3 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 19F at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 20 at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 21 at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 22F at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 23A at Year 2:R | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 23B at Year 2:R | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 31 at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 33A at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 33F at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 34 at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 35B at Year 2:R | 9.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 35F at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 38 at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype clumps at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype Missing/non-viable at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 3 at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 6C at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 7C at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 9N at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 10 at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 11 at Year 3:R | 1.8 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 12 at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 12F at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 13 at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 15A at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 15B at Year 3:R | 1.8 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 15C at Year 3:R | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 15F at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 16 at Year 3:R | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 17 at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 19A at Year 3:R | 6.3 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 19F at Year 3:R | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 20 at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 21 at Year 3:R | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 22F at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 23A at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 23B at Year 3:R | 2.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 31 at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 33A at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 33F at Year 3:R | 1.8 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 34 at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 35B at Year 3:R | 5.4 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 35F at Year 3:R | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype 38 at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype clumps at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Erythromycin: Middle Ear Fluid (MEF) Population | Serotype Missing/non-viable at Year 3:R | 0.9 percentage of isolates |
Secondary
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population
Antimicrobial susceptibility of S pneumoniae isolates for penicillin from mastoid samples was categorized as resistant, susceptible or intermediate based on MIC for each serotype at each year of the whole surveillance period. The percentage of S pneumoniae serotypes included 3, 12, 15A, 15B, 15F, 19A, 19F, 21, 22F, 23A, 38, which were to be computed along with exact 2-sided 95% CI based on the observed proportion of isolates. 'Number of isolates analyzed' signifies total number of isolates that were evaluable for this OM.
Time frame: Surveillance Year 1, 2, 3
Population: Mastoid population. N (number of participants analyzed) includes total number of participants in mastoid population, however actual 'N' for this OM is unknown as this data were not calculated as per planned analysis and number analyzed=number of isolates for the given serotype at specified time point.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population | Serotype 3 at Year 1:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population | Serotype 12 at Year 1:S | 5.6 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population | Serotype 15A at Year 1:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population | Serotype 15B at Year 1:S | 5.6 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population | Serotype 15F at Year 1:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population | Serotype 19A at Year 1:S | 5.6 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population | Serotype 19F at Year 1:S | 5.6 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population | Serotype 21 at Year 1:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population | Serotype 22F at Year 1:S | 11.1 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population | Serotype 23A at Year 1:S | 5.6 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population | Serotype 38 at Year 1:S | 5.6 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population | Serotype 3 at Year 2:S | 28.6 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population | Serotype 12 at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population | Serotype 15A at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population | Serotype 15B at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population | Serotype 15F at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population | Serotype 19A at Year 2:S | 14.3 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population | Serotype 19F at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population | Serotype 21 at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population | Serotype 22F at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population | Serotype 23A at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population | Serotype 38 at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population | Serotype 3 at Year 3:S | 44.4 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population | Serotype 12 at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population | Serotype 15A at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population | Serotype 15B at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population | Serotype 15F at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population | Serotype 19A at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population | Serotype 19F at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population | Serotype 21 at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population | Serotype 22F at Year 3:S | 11.1 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population | Serotype 23A at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population | Serotype 38 at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population | Serotype 3 at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population | Serotype 12 at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population | Serotype 15A at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population | Serotype 15B at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population | Serotype 15F at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population | Serotype 19A at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population | Serotype 19F at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population | Serotype 21 at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population | Serotype 22F at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population | Serotype 23A at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population | Serotype 38 at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population | Serotype 3 at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population | Serotype 12 at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population | Serotype 15A at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population | Serotype 15B at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population | Serotype 15F at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population | Serotype 19A at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population | Serotype 19F at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population | Serotype 21 at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population | Serotype 22F at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population | Serotype 23A at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population | Serotype 38 at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population | Serotype 3 at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population | Serotype 12 at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population | Serotype 15A at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population | Serotype 15B at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population | Serotype 15F at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population | Serotype 19A at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population | Serotype 19F at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population | Serotype 21 at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population | Serotype 22F at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population | Serotype 23A at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population | Serotype 38 at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population | Serotype 3 at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population | Serotype 12 at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population | Serotype 15A at Year 1:R | 5.6 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population | Serotype 15B at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population | Serotype 15F at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population | Serotype 19A at Year 1:R | 33.3 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population | Serotype 19F at Year 1:R | 5.6 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population | Serotype 21 at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population | Serotype 22F at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population | Serotype 23A at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population | Serotype 38 at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population | Serotype 3 at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population | Serotype 12 at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population | Serotype 15A at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population | Serotype 15B at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population | Serotype 15F at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population | Serotype 19A at Year 2:R | 57.1 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population | Serotype 19F at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population | Serotype 21 at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population | Serotype 22F at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population | Serotype 23A at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population | Serotype 38 at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population | Serotype 3 at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population | Serotype 12 at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population | Serotype 15A at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population | Serotype 15B at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population | Serotype 15F at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population | Serotype 19A at Year 3:R | 11.1 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population | Serotype 19F at Year 3:R | 11.1 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population | Serotype 21 at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population | Serotype 22F at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population | Serotype 23A at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Mastoid Population | Serotype 38 at Year 3:R | 0.0 percentage of isolates |
Secondary
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population
Antimicrobial susceptibility of S pneumoniae isolates for penicillin from MEF samples were summarized by providing the range of MICs for penicillin tested and the percentage of the susceptibility interpretation was categorized as resistant, susceptible or intermediate for each serotype, and for each year of the whole surveillance period. The percentage of S pneumoniae serotypes included 3, 6C, 7C, 9N, 10, 11, 12, 12F, 13, 15A, 15B, 15C, 15F, 16, 17, 19 A, 19 F, 20, 21, 22F, 23A, 23B, 31, 33A, 33F, 34, 35B, 35F, 38, clumps and missing or non-viable, which were to be computed along with exact 2-sided 95 % CI based on the observed proportion of isolates. Missing or non-viable included isolates that were either not sent from an external laboratory, were non-viable or lost on culture prior to sending, or were non-viable on receipt in the central laboratory.'Number of isolates analyzed' signifies total number of isolates that were evaluable for this OM.
Time frame: Surveillance Year 1, 2, 3
Population: MEF population included all participants who have at least 1 S pneumoniae isolate from MEF samples, however, actual 'N' for this OM is unknown as these data were not calculated as per planned analysis. number analyzed=number of isolates for the given serotype at specified time point.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 15C at Year 2:I | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 15F at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 16 at Year 2:I | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 17 at Year 2:I | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 19A at Year 2:I | 1.8 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 19F at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 20 at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 21 at Year 2:I | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 22F at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 23A at Year 2:I | 4.5 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 23B at Year 2:I | 3.6 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 31 at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 33A at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 33F at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 34 at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 35B at Year 2:I | 9.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 35F at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 38 at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype clumps at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype Missing/non-viable at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 3 at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 6C at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 7C at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 9N at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 10 at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 11 at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 12 at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 12F at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 13 at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 15A at Year 3:I | 1.8 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 15B at Year 3:I | 2.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 15C at Year 3:I | 2.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 15F at Year 3:I | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 16 at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 17 at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 19A at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 19F at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 20 at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 21 at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 22F at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 23A at Year 3:I | 1.8 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 23B at Year 3:I | 1.8 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 31 at Year 3:I | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 33A at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 33F at Year 3:I | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 34 at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 35B at Year 3:I | 6.3 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 35F at Year 3:I | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 38 at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype clumps at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype Missing/non-viable at Year 3:I | 1.8 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 3 at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 6C at Year 1:R | 0.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 7C at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 9N at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 10 at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 11 at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 12 at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 12F at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 13 at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 15A at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 15B at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 15C at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 15F at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 16 at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 17 at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 19A at Year 1:R | 25.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 19F at Year 1:R | 0.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 20 at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 3 at Year 1:S | 5.2 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 7C at Year 1:S | 1.5 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 9N at Year 1:S | 2.2 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 10 at Year 1:S | 3.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 11 at Year 1:S | 3.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 12 at Year 1:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 12F at Year 1:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 21 at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 22F at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 23A at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 23B at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 31 at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 33A at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 13 at Year 1:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 15A at Year 1:S | 0.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 15B at Year 1:S | 3.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 15C at Year 1:S | 1.5 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 15F at Year 1:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 33F at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 34 at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 35B at Year 1:R | 1.5 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 35F at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 38 at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 16 at Year 1:S | 1.5 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 17 at Year 1:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype clumps at Year 1:R | 0.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype Missing/non-viable at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 3 at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 19A at Year 1:S | 2.2 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 6C at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 7C at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 19F at Year 1:S | 0.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 20 at Year 1:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 21 at Year 1:S | 3.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 22F at Year 1:S | 1.5 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 9N at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 10 at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 11 at Year 2:R | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 12 at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 12F at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 13 at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 23A at Year 1:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 23B at Year 1:S | 0.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 31 at Year 1:S | 2.2 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 33A at Year 1:S | 0.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 15A at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 15B at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 15C at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 15F at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 16 at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 33F at Year 1:S | 1.5 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 17 at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 19A at Year 2:R | 18.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 19F at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 20 at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 21 at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 22F at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 23A at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 23B at Year 2:R | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 31 at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 33A at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 33F at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 34 at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 35B at Year 2:R | 1.8 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 35F at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 38 at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype clumps at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype Missing/non-viable at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 3 at Year 3:R | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 6C at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 7C at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 9N at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 10 at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 11 at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 12 at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 12F at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 13 at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 15A at Year 3:R | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 15B at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 15C at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 15F at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 16 at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 17 at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 19A at Year 3:R | 9.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 19F at Year 3:R | 1.8 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 20 at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 21 at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 22F at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 23A at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 23B at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 31 at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 33A at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 33F at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 34 at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 35B at Year 3:R | 2.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 35F at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 38 at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype clumps at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype Missing/non-viable at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 34 at Year 1:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 35B at Year 1:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 35F at Year 1:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 38 at Year 1:S | 0.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype clumps at Year 1:S | 0.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype Missing/non-viable at Year 1:S | 1.5 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 3 at Year 2:S | 6.3 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 6C at Year 2:S | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 7C at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 9N at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 10 at Year 2:S | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 11 at Year 2:S | 6.3 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 12 at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 12F at Year 2:S | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 13 at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 15A at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 15B at Year 2:S | 1.8 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 15C at Year 2:S | 1.8 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 15F at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 16 at Year 2:S | 1.8 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 17 at Year 2:S | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 19A at Year 2:S | 1.8 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 19F at Year 2:S | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 20 at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 21 at Year 2:S | 8.1 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 22F at Year 2:S | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 23A at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 23B at Year 2:S | 2.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 31 at Year 2:S | 1.8 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 33A at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 33F at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 34 at Year 2:S | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 35B at Year 2:S | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 35F at Year 2:S | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 38 at Year 2:S | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype clumps at Year 2:S | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype Missing/non-viable at Year 2:S | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 3 at Year 3:S | 6.3 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 6C at Year 3:S | 1.8 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 7C at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 9N at Year 3:S | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 10 at Year 3:S | 2.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 11 at Year 3:S | 3.6 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 12 at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 12F at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 13 at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 15A at Year 3:S | 3.6 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 15B at Year 3:S | 1.8 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 15C at Year 3:S | 2.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 15F at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 16 at Year 3:S | 4.5 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 17 at Year 3:S | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 19A at Year 3:S | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 19F at Year 3:S | 3.6 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 20 at Year 3:S | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 21 at Year 3:S | 5.4 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 22F at Year 3:S | 2.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 23A at Year 3:S | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 23B at Year 3:S | 6.3 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 31 at Year 3:S | 3.6 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 33A at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 33F at Year 3:S | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 34 at Year 3:S | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 35B at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 35F at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 38 at Year 3:S | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype clumps at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype Missing/non-viable at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 6C at Year 1:S | 2.2 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 3 at Year 1:I | 0.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 6C at Year 1:I | 3.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 7C at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 9N at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 10 at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 11 at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 12 at Year 1:I | 0.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 12F at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 13 at Year 1:I | 0.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 15A at Year 1:I | 3.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 15B at Year 1:I | 0.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 15C at Year 1:I | 2.2 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 15F at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 16 at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 17 at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 19A at Year 1:I | 2.2 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 19F at Year 1:I | 0.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 20 at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 21 at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 22F at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 23A at Year 1:I | 3.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 23B at Year 1:I | 0.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 31 at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 33A at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 33F at Year 1:I | 1.5 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 34 at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 35B at Year 1:I | 5.2 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 35F at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 38 at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype clumps at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype Missing/non-viable at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 3 at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 6C at Year 2:I | 2.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 7C at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 9N at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 10 at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 11 at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 12 at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 12F at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 13 at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 15A at Year 2:I | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Penicillin: Middle Ear Fluid (MEF) Population | Serotype 15B at Year 2:I | 2.7 percentage of isolates |
Secondary
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population
Antimicrobial susceptibility of S pneumoniae isolates for TMP/S from mastoid samples was categorized as resistant, susceptible or intermediate based on MIC for each serotype at each year of the whole surveillance period. The percentage of S pneumoniae serotypes included 3, 12, 15A, 15B, 15F, 19A, 19F, 21, 22F, 23A, 38, which were to be computed along with exact 2-sided 95% CI based on the observed proportion of isolates. 'Number of isolates analyzed' signifies total number of isolates that were evaluable for this OM.
Time frame: Surveillance Year 1, 2, 3
Population: Mastoid population. N (number of participants analyzed) includes total number of participants in mastoid population, however actual 'N' for this OM is unknown as this data were not calculated as per planned analysis and number analyzed=number of isolates for the given serotype at specified time point.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population | Serotype 3 at Year 1:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population | Serotype 12 at Year 1:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population | Serotype 15A at Year 1:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population | Serotype 15B at Year 1:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population | Serotype 15F at Year 1:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population | Serotype 19A at Year 1:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population | Serotype 19F at Year 1:S | 5.6 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population | Serotype 21 at Year 1:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population | Serotype 22F at Year 1:S | 5.6 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population | Serotype 23A at Year 1:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population | Serotype 38 at Year 1:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population | Serotype 3 at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population | Serotype 12 at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population | Serotype 15A at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population | Serotype 15B at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population | Serotype 15F at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population | Serotype 19A at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population | Serotype 19F at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population | Serotype 21 at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population | Serotype 22F at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population | Serotype 23A at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population | Serotype 38 at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population | Serotype 3 at Year 3:S | 33.3 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population | Serotype 12 at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population | Serotype 15A at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population | Serotype 15B at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population | Serotype 15F at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population | Serotype 19A at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population | Serotype 19F at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population | Serotype 21 at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population | Serotype 22F at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population | Serotype 23A at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population | Serotype 38 at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population | Serotype 3 at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population | Serotype 12 at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population | Serotype 15A at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population | Serotype 15B at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population | Serotype 15F at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population | Serotype 19A at Year 1:I | 5.6 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population | Serotype 19F at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population | Serotype 21 at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population | Serotype 22F at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population | Serotype 23A at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population | Serotype 38 at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population | Serotype 3 at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population | Serotype 12 at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population | Serotype 15A at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population | Serotype 15B at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population | Serotype 15F at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population | Serotype 19A at Year 2:I | 28.6 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population | Serotype 19F at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population | Serotype 21 at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population | Serotype 22F at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population | Serotype 23A at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population | Serotype 38 at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population | Serotype 3 at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population | Serotype 12 at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population | Serotype 15A at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population | Serotype 15B at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population | Serotype 15F at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population | Serotype 19A at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population | Serotype 19F at Year 3:I | 11.1 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population | Serotype 21 at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population | Serotype 22F at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population | Serotype 23A at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population | Serotype 38 at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population | Serotype 3 at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population | Serotype 12 at Year 1:R | 5.6 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population | Serotype 15A at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population | Serotype 15B at Year 1:R | 5.6 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population | Serotype 15F at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population | Serotype 19A at Year 1:R | 22.2 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population | Serotype 19F at Year 1:R | 5.6 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population | Serotype 21 at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population | Serotype 22F at Year 1:R | 5.6 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population | Serotype 23A at Year 1:R | 5.6 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population | Serotype 38 at Year 1:R | 5.6 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population | Serotype 3 at Year 2:R | 28.6 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population | Serotype 12 at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population | Serotype 15A at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population | Serotype 15B at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population | Serotype 15F at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population | Serotype 19A at Year 2:R | 42.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population | Serotype 19F at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population | Serotype 21 at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population | Serotype 22F at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population | Serotype 23A at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population | Serotype 38 at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population | Serotype 3 at Year 3:R | 11.1 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population | Serotype 12 at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population | Serotype 15A at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population | Serotype 15B at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population | Serotype 15F at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population | Serotype 19A at Year 3:R | 11.1 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population | Serotype 19F at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population | Serotype 21 at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population | Serotype 22F at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population | Serotype 23A at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Mastoid Population | Serotype 38 at Year 3:R | 0.0 percentage of isolates |
Secondary
Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population
Antimicrobial susceptibility of S pneumoniae isolates for TMP/S from MEF samples was categorized as resistant, susceptible or intermediate based on MIC for each serotype at each year of the whole surveillance period. The percentage of S pneumoniae serotypes included 3, 6C, 7C, 9N, 10, 11, 12, 12F, 13, 15A, 15B, 15C, 15F, 16, 17, 19A, 19F, 20, 21, 22F, 23A, 23B, 31, 33A, 33F, 34, 35B, 35F, 38, clumps and missing or non-viable, which were to be computed along with exact 2-sided 95% CI based on the observed proportion of isolates. Missing or non-viable included isolates that were either not sent from an external laboratory, were non-viable or lost on culture prior to sending, or were non-viable on receipt in the central laboratory.'Number of isolates analyzed' signifies total number of isolates that were evaluable for this OM.
Time frame: Surveillance Year 1, 2, 3
Population: MEF population. N (number of participants analyzed) includes total number of participants in MEF population, however actual 'N' for this OM is unknown as this data were not calculated as per planned analysis and number analyzed=number of isolates for the given serotype at specified time point.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 3 at Year 1:S | 3.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 6C at Year 1:S | 0.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 7C at Year 1:S | 1.5 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 9N at Year 1:S | 1.5 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 10 at Year 1:S | 0.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 11 at Year 1:S | 2.2 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 12 at Year 1:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 12F at Year 1:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 13 at Year 1:S | 0.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 15A at Year 1:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 15B at Year 1:S | 1.5 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 15C at Year 1:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 15F at Year 1:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 16 at Year 1:S | 1.5 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 17 at Year 1:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 19A at Year 1:S | 0.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 19F at Year 1:S | 0.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 20 at Year 1:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 21 at Year 1:S | 1.5 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 22F at Year 1:S | 0.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 23A at Year 1:S | 0.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 23B at Year 1:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 31 at Year 1:S | 0.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 33A at Year 1:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 33F at Year 1:S | 0.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 34 at Year 1:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 35B at Year 1:S | 0.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 35F at Year 1:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 38 at Year 1:S | 0.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype clumps at Year 1:S | 0.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype Missing/non-viable at Year 1:S | 0.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 3 at Year 2:S | 1.8 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 6C at Year 2:S | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 7C at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 9N at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 10 at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 11 at Year 2:S | 3.6 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 12 at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 12F at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 13 at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 15A at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 15B at Year 2:S | 1.8 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 15C at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 15F at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 16 at Year 2:S | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 17 at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 19A at Year 2:S | 1.8 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 19F at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 20 at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 21 at Year 2:S | 3.6 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 22F at Year 2:S | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 23A at Year 2:S | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 23B at Year 2:S | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 31 at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 33A at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 33F at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 34 at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 35B at Year 2:S | 2.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 35F at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 38 at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype clumps at Year 2:S | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype Missing/non-viable at Year 2:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 3 at Year 3:S | 2.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 6C at Year 3:S | 1.8 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 7C at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 9N at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 10 at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 11 at Year 3:S | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 12 at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 12F at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 13 at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 15A at Year 3:S | 1.8 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 15B at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 15C at Year 3:S | 2.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 15F at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 16 at Year 3:S | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 17 at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 19A at Year 3:S | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 19F at Year 3:S | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 20 at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 21 at Year 3:S | 3.6 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 22F at Year 3:S | 2.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 23A at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 23B at Year 3:S | 1.8 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 31 at Year 3:S | 1.8 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 33A at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 33F at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 34 at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 35B at Year 3:S | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 35F at Year 3:S | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 38 at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype clumps at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype Missing/non-viable at Year 3:S | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 3 at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 6C at Year 1:I | 1.5 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 7C at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 9N at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 10 at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 11 at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 12 at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 12F at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 13 at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 15A at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 15B at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 15C at Year 1:I | 0.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 15F at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 16 at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 17 at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 19A at Year 1:I | 14.1 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 19F at Year 1:I | 0.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 20 at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 21 at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 22F at Year 1:I | 0.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 23A at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 23B at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 31 at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 33A at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 33F at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 34 at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 35B at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 35F at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 38 at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype clumps at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype Missing/non-viable at Year 1:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 3 at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 6C at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 7C at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 9N at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 10 at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 11 at Year 2:I | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 12 at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 12F at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 13 at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 15A at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 15B at Year 2:I | 1.8 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 15C at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 15F at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 16 at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 17 at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 19A at Year 2:I | 12.6 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 19F at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 20 at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 21 at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 22F at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 23A at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 23B at Year 2:I | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 31 at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 33A at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 33F at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 34 at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 35B at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 35F at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 38 at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype clumps at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype Missing/non-viable at Year 2:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 3 at Year 3:I | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 6C at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 7C at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 9N at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 10 at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 11 at Year 3:I | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 12 at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 12F at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 13 at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 15A at Year 3:I | 1.8 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 15B at Year 3:I | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 15C at Year 3:I | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 15F at Year 3:I | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 16 at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 17 at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 19A at Year 3:I | 2.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 19F at Year 3:I | 2.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 20 at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 21 at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 22F at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 23A at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 23B at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 31 at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 33A at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 33F at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 34 at Year 3:I | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 35B at Year 3:I | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 35F at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 38 at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype clumps at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype Missing/non-viable at Year 3:I | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 3 at Year 1:R | 3.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 6C at Year 1:R | 4.4 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 7C at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 9N at Year 1:R | 0.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 10 at Year 1:R | 1.5 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 11 at Year 1:R | 1.5 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 12 at Year 1:R | 0.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 12F at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 13 at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 15A at Year 1:R | 3.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 15B at Year 1:R | 2.2 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 15C at Year 1:R | 3.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 15F at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 16 at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 17 at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 19A at Year 1:R | 15.6 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 19F at Year 1:R | 0.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 20 at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 21 at Year 1:R | 1.5 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 22F at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 23A at Year 1:R | 2.2 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 23B at Year 1:R | 0.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 31 at Year 1:R | 1.5 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 33A at Year 1:R | 0.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 33F at Year 1:R | 2.2 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 34 at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 35B at Year 1:R | 5.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 35F at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 38 at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype clumps at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype Missing/non-viable at Year 1:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 3 at Year 2:R | 4.5 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 6C at Year 2:R | 2.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 7C at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 9N at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 10 at Year 2:R | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 11 at Year 2:R | 2.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 12 at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 12F at Year 2:R | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 13 at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 15A at Year 2:R | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 15B at Year 2:R | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 15C at Year 2:R | 2.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 15F at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 16 at Year 2:R | 1.8 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 17 at Year 2:R | 1.8 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 19A at Year 2:R | 8.1 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 19F at Year 2:R | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 20 at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 21 at Year 2:R | 4.5 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 22F at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 23A at Year 2:R | 3.6 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 23B at Year 2:R | 5.4 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 31 at Year 2:R | 1.8 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 33A at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 33F at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 34 at Year 2:R | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 35B at Year 2:R | 9.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 35F at Year 2:R | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 38 at Year 2:R | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype clumps at Year 2:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype Missing/non-viable at Year 2:R | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 3 at Year 3:R | 3.6 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 6C at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 7C at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 9N at Year 3:R | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 10 at Year 3:R | 2.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 11 at Year 3:R | 1.8 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 12 at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 12F at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 13 at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 15A at Year 3:R | 2.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 15B at Year 3:R | 3.6 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 15C at Year 3:R | 1.8 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 15F at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 16 at Year 3:R | 3.6 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 17 at Year 3:R | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 19A at Year 3:R | 6.3 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 19F at Year 3:R | 1.8 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 20 at Year 3:R | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 21 at Year 3:R | 1.8 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 22F at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 23A at Year 3:R | 2.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 23B at Year 3:R | 6.3 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 31 at Year 3:R | 2.7 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 33A at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 33F at Year 3:R | 1.8 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 34 at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 35B at Year 3:R | 9.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 35F at Year 3:R | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype 38 at Year 3:R | 0.9 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype clumps at Year 3:R | 0.0 percentage of isolates |
| MEF Population | Antimicrobial Susceptibility of Streptococcus Pneumoniae Isolates for Trimethoprim/Sulfamethoxazole (TMP/S): Middle Ear Fluid (MEF) Population | Serotype Missing/non-viable at Year 3:R | 1.8 percentage of isolates |
Secondary
Percentage of Participants With Primary Clinical Diagnosis of Mastoiditis
Percentage of participants with primary diagnosis of mastoiditis was computed along with exact 2-sided 95% CI based on the observed proportion of participants for each of the 3 surveillance year. Percentage of participants was calculated by dividing number of participants with at least 1 mastoid sample for the specified year by total number of participants with at least 1 mastoid sample for the 3 year surveillance period.
Time frame: Surveillance Year 1, 2, 3
Population: Mastoid population included all participants who have at least 1 S pneumoniae isolate from mastoid samples surveillance period. N(number of participants analyzed) includes total number of participants in mastoid population.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| MEF Population | Percentage of Participants With Primary Clinical Diagnosis of Mastoiditis | Surveillance Year 3 | 26.5 percentage of participants |
| MEF Population | Percentage of Participants With Primary Clinical Diagnosis of Mastoiditis | Surveillance Year 1 | 52.9 percentage of participants |
| MEF Population | Percentage of Participants With Primary Clinical Diagnosis of Mastoiditis | Surveillance Year 2 | 20.6 percentage of participants |
Secondary
Percentage of Participants With Primary Clinical Diagnosis of Otitis Media
Percentage of participants with primary diagnosis of otitis media was computed along with exact 2-sided 95% CI based on the observed proportion of participants for each of the 3 surveillance year. Results for baseline period were analyzed for participants who received routinely recommended vaccination of 13vPnC. The cases of otitis media reported during the baseline period were captured by the Texas Children's Hospital, which was the only site that collected this information during the baseline period. Percentage of participants was calculated by dividing number of participants with at least 1 MEF sample for the specified year by total number of participants with at least 1 MEF sample for the 3 year surveillance period.
Time frame: Baseline Year 1, 2, 3; Surveillance Year 1, 2, 3
Population: MEF population included all participants who have at least 1 S pneumoniae isolate from MEF samples during baseline (2007-2009) and surveillance (2011-2013) period.N(number of participants analyzed) includes total number of participants in MEF population and n=number of participants for the specified time point.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| MEF Population | Percentage of Participants With Primary Clinical Diagnosis of Otitis Media | Baseline Year 1: 2007 | 24.0 percentage of participants |
| MEF Population | Percentage of Participants With Primary Clinical Diagnosis of Otitis Media | Baseline Year 2: 2008 | 45.3 percentage of participants |
| MEF Population | Percentage of Participants With Primary Clinical Diagnosis of Otitis Media | Surveillance Year 1: 2011 | 37.8 percentage of participants |
| MEF Population | Percentage of Participants With Primary Clinical Diagnosis of Otitis Media | Surveillance Year 2: 2012 | 31.1 percentage of participants |
| MEF Population | Percentage of Participants With Primary Clinical Diagnosis of Otitis Media | Surveillance Year 3: 2013 | 31.1 percentage of participants |
| MEF Population | Percentage of Participants With Primary Clinical Diagnosis of Otitis Media | Baseline Year 3: 2009 | 30.7 percentage of participants |